Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Autoimmune Disorders

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 763 articles:
HTML format

Single Articles

    January 2021
  1. ZUCCHI D, Tani C, Elefante E, Stagnaro C, et al
    Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
    PLoS One. 2021;16:e0245274.
    PubMed     Abstract available

  2. RUIZ-QUINONEZ JA, Guzman-Priego CG, Nolasco-Rosales GA, Tovilla-Zarate CA, et al
    Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
    PLoS One. 2021;16:e0245394.
    PubMed     Abstract available

  3. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    PubMed     Abstract available

  4. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    PubMed     Abstract available

  5. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    PubMed     Abstract available

  6. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available

  7. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    PubMed     Abstract available

  8. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    PubMed     Abstract available

  9. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    PubMed     Abstract available

  10. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available

  11. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    PubMed     Abstract available

  12. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    PubMed     Abstract available

  13. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    PubMed     Abstract available

  14. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    PubMed     Abstract available

  15. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    PubMed     Abstract available

  16. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    PubMed     Abstract available

  17. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    PubMed     Abstract available

  18. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    PubMed     Abstract available

  19. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available

  20. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    PubMed     Abstract available

  21. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    PubMed     Abstract available

  22. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    PubMed     Abstract available

  23. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    PubMed     Abstract available

  24. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    PubMed     Abstract available

  25. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    PubMed     Abstract available

  26. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    PubMed     Abstract available

  27. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    PubMed     Abstract available

  28. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    PubMed     Abstract available

    January 2020
  29. LI Z, Rotival M, Patin E, Michel F, et al
    Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
    PLoS One. 2020;15:e0225289.
    PubMed     Abstract available

  30. MATSUOKA N, Fujita Y, Temmoku J, Furuya MY, et al
    Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    PLoS One. 2020;15:e0227069.
    PubMed     Abstract available

  31. JANG S, Kim JH, Choi SY, Park SJ, et al
    Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes.
    PLoS One. 2020;15:e0227492.
    PubMed     Abstract available

  32. PLAZINSKA MT, Sawicka-Gutaj N, Czarnywojtek A, Wolinski K, et al
    Radioiodine therapy and Graves' disease - Myths and reality.
    PLoS One. 2020;15:e0226495.
    PubMed     Abstract available

  33. OGAWA-AKIYAMA A, Sugiyama H, Kitagawa M, Tanaka K, et al
    Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    PLoS One. 2020;15:e0228337.
    PubMed     Abstract available

  34. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available

  35. AHMED CM, Ildefonso CJ, Johnson HM, Lewin AS, et al
    A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
    PLoS One. 2020;15:e0227524.
    PubMed     Abstract available

  36. CHEWCHARAT A, Chewcharat P, Rutirapong A, Papatheodorou S, et al
    The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0228315.
    PubMed     Abstract available

  37. PELLEGRINO M, Traversi G, Arena A, Cappa M, et al
    Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.
    PLoS One. 2020;15:e0228296.
    PubMed     Abstract available

  38. PENG YH, Lin YS, Chen CH, Tsai KY, et al
    Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
    PLoS One. 2020;15:e0226997.
    PubMed     Abstract available

  39. HOSONUMA M, Yajima N, Takahashi R, Yanai R, et al
    Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.
    PLoS One. 2020;15:e0227022.
    PubMed     Abstract available

  40. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed     Abstract available

  41. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    PubMed     Abstract available

  42. HJORTH M, Dandu N, Mellergard J
    Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    PLoS One. 2020;15:e0228380.
    PubMed     Abstract available

  43. GRANER M, Pointon T, Manton S, Green M, et al
    Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
    PLoS One. 2020;15:e0228883.
    PubMed     Abstract available

  44. ZWINGLI G, Yerly J, Mivelaz Y, Stoppa-Vaucher S, et al
    Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study.
    PLoS One. 2020;15:e0228569.
    PubMed     Abstract available

  45. GIOVANNETTI AM, Pietrolongo E, Borreani C, Giordano A, et al
    Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.
    PLoS One. 2020;15:e0228587.
    PubMed     Abstract available

  46. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available

  47. AUNGSUMART S, Apiwattanakul M
    Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    PLoS One. 2020;15:e0229028.
    PubMed     Abstract available

  48. YALACHKOV Y, Uhlmann V, Bergmann J, Soydas D, et al
    Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance.
    PLoS One. 2020;15:e0228679.
    PubMed     Abstract available

  49. BRANT EJ, Rietman EA, Klement GL, Cavaglia M, et al
    Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks.
    PLoS One. 2020;15:e0226883.
    PubMed     Abstract available

  50. EVERS J, Grotenhuis AJ, Aben KKH, Kiemeney LALM, et al
    No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    PLoS One. 2020;15:e0229384.
    PubMed     Abstract available

  51. SAGAR D, Gaddipati R, Ongstad EL, Bhagroo N, et al
    LOX-1: A potential driver of cardiovascular risk in SLE patients.
    PLoS One. 2020;15:e0229184.
    PubMed     Abstract available

  52. JULIAN GS, Rosim RP, Carneseca EC, Rigolon J, et al
    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
    PLoS One. 2020;15:e0229768.
    PubMed     Abstract available

  53. GONGORA-RIVERA F, Grijalva I, Infante-Valenzuela A, Camara-Lemarroy C, et al
    Zika Virus infection and Guillain-Barre syndrome in Northeastern Mexico: A case-control study.
    PLoS One. 2020;15:e0230132.
    PubMed     Abstract available

  54. RAMESH J, Parthasarathy LK, Janckila AJ, Begum F, et al
    Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia.
    PLoS One. 2020;15:e0230052.
    PubMed     Abstract available

  55. MASTRACCI TL, Colvin SC, Padgett LR, Mirmira RG, et al
    Hypusinated eIF5A is expressed in the pancreas and spleen of individuals with type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0230627.
    PubMed     Abstract available

  56. SECCIA R, Gammelli D, Dominici F, Romano S, et al
    Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis.
    PLoS One. 2020;15:e0230219.
    PubMed     Abstract available

  57. NOWLING TK, Rodgers J, Thiyagarajan T, Wolf B, et al
    Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    PLoS One. 2020;15:e0230499.
    PubMed     Abstract available

  58. MORIKAWA M, Kato-Hirayama E, Mayama M, Saito Y, et al
    Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy.
    PLoS One. 2020;15:e0230488.
    PubMed     Abstract available

  59. SELGRADE BP, Meyer D, Sosnoff JJ, Franz JR, et al
    Can optical flow perturbations detect walking balance impairment in people with multiple sclerosis?
    PLoS One. 2020;15:e0230202.
    PubMed     Abstract available

  60. SILVA T, Fragoso YD, Destro Rodrigues MFS, Gomes AO, et al
    Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis - Randomized clinical trial.
    PLoS One. 2020;15:e0230551.
    PubMed     Abstract available

  61. MASUDA H, Mori M, Uzawa A, Uchida T, et al
    Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    PLoS One. 2020;15:e0224419.
    PubMed     Abstract available

  62. FOOLAD F, Khodagholi F, Nabavi SM, Javan M, et al
    Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.
    PLoS One. 2020;15:e0230691.
    PubMed     Abstract available

  63. SAURI-SUAREZ S, Quinones-Aguilar S, Contreras-Marin A, Ramiro-Guerrero EO, et al
    Adherence to self-administering interferon-beta1a using RebiSmart(R) device in Mexican patients with relapsing multiple sclerosis.
    PLoS One. 2020;15:e0230959.
    PubMed     Abstract available

  64. POLSKY S, Garcetti R, Pyle L, Joshee P, et al
    Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    PLoS One. 2020;15:e0230476.
    PubMed     Abstract available

  65. GIOVANNETTI AM, Quintas R, Tramacere I, Giordano A, et al
    A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
    PLoS One. 2020;15:e0231380.
    PubMed     Abstract available

  66. HASHEMI R, Hosseini-Asl SS, Arefhosseini SR, Morshedi M, et al
    The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
    PLoS One. 2020;15:e0231145.
    PubMed     Abstract available

  67. NINOU I, Sevastou I, Magkrioti C, Kaffe E, et al
    Genetic deletion of Autotaxin from CD11b+ cells decreases the severity of experimental autoimmune encephalomyelitis.
    PLoS One. 2020;15:e0226050.
    PubMed     Abstract available

  68. PARRAVICINI C, Lecca D, Marangon D, Coppolino GT, et al
    Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis.
    PLoS One. 2020;15:e0231483.
    PubMed     Abstract available

  69. ZHANG X, Liu L, Ma X, Hu W, et al
    Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE.
    PLoS One. 2020;15:e0231622.
    PubMed     Abstract available

  70. MANNERING N, Hansen DL, Frederiksen H
    Evans syndrome in children below 13 years of age - A nationwide population-based cohort study.
    PLoS One. 2020;15:e0231284.
    PubMed     Abstract available

  71. AKAISHI T, Takahashi T, Fujihara K, Misu T, et al
    Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
    PLoS One. 2020;15:e0231225.
    PubMed     Abstract available

  72. GORDON RA, Tilstra JS, Marinov A, Nickerson KM, et al
    Murine lupus is neutrophil elastase-independent in the MRL.Faslpr model.
    PLoS One. 2020;15:e0226396.
    PubMed     Abstract available

  73. BARRERO F, Mallada-Frechin J, Martinez-Gines ML, Marzo ME, et al
    Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
    PLoS One. 2020;15:e0230846.
    PubMed     Abstract available

  74. OHLMEIER C, Gothe H, Haas J, Osowski U, et al
    Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    PLoS One. 2020;15:e0231846.
    PubMed     Abstract available

  75. SUGIYAMA M, Wada Y, Kanazawa N, Tachibana S, et al
    A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy.
    PLoS One. 2020;15:e0232194.
    PubMed     Abstract available

  76. GOITIA B, Bruno D, Abrevaya S, Sedeno L, et al
    The relationship between executive functions and fluid intelligence in multiple sclerosis.
    PLoS One. 2020;15:e0231868.
    PubMed     Abstract available

  77. VAN DE KREEKE JA, Darma S, Chan Pin Yin JMPL, Tan HS, et al
    The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy.
    PLoS One. 2020;15:e0231552.
    PubMed     Abstract available

  78. ABREGO-PEREDO A, Romero-Ramirez H, Espinosa E, Lopez-Herrera G, et al
    Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
    PLoS One. 2020;15:e0233138.
    PubMed     Abstract available

  79. HOLTE KB, Svanteson M, Hanssen KF, Sveen KA, et al
    Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study.
    PLoS One. 2020;15:e0233174.
    PubMed     Abstract available

  80. KIM SH, Rhee Y, Kim YM, Won YJ, et al
    Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study.
    PLoS One. 2020;15:e0232842.
    PubMed     Abstract available

  81. KATAOKA H, Ohara M, Suzuki T, Inoue T, et al
    Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    PLoS One. 2020;15:e0232885.
    PubMed     Abstract available

  82. LUCCHETTA RC, Leonart LP, Goncalves MVM, Becker J, et al
    Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2020;15:e0231722.
    PubMed     Abstract available

  83. BROWN FS, Glasmacher SA, Kearns PKA, MacDougall N, et al
    Systematic review of prediction models in relapsing remitting multiple sclerosis.
    PLoS One. 2020;15:e0233575.
    PubMed     Abstract available

  84. VAN JAD, Clotet-Freixas S, Hauschild AC, Batruch I, et al
    Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes.
    PLoS One. 2020;15:e0233639.
    PubMed     Abstract available

  85. SAKONO T, Meguro A, Takeuchi M, Yamane T, et al
    Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
    PLoS One. 2020;15:e0233464.
    PubMed     Abstract available

  86. KUSNIEROVA P, Zeman D, Hradilek P, Zapletalova O, et al
    Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    PLoS One. 2020;15:e0233519.
    PubMed     Abstract available

  87. PAMPHLETT R, Mak R, Lee J, Buckland ME, et al
    Concentrations of toxic metals and essential trace elements vary among individual neurons in the human locus ceruleus.
    PLoS One. 2020;15:e0233300.
    PubMed     Abstract available

  88. IMAI E, Usui J, Kaneko S, Kawamura T, et al
    The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.
    PLoS One. 2020;15:e0233186.
    PubMed     Abstract available

  89. GILLEY KN, Wierenga KA, Chauhuan PS, Wagner JG, et al
    Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
    PLoS One. 2020;15:e0233183.
    PubMed     Abstract available

  90. MURATA T, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study.
    PLoS One. 2020;15:e0233883.
    PubMed     Abstract available

  91. BHATIA SM, Streilein RD, Hall RP
    Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    PLoS One. 2020;15:e0233957.
    PubMed     Abstract available

  92. BAUER A, Lechner I, Auer M, Berger T, et al
    Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.
    PLoS One. 2020;15:e0234333.
    PubMed     Abstract available

  93. MORKHOLT AS, Oklinski MK, Larsen A, Bockermann R, et al
    Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
    PLoS One. 2020;15:e0234493.
    PubMed     Abstract available

  94. MORALES PANTOJA IE, Smith MD, Rajbhandari L, Cheng L, et al
    iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.
    PLoS One. 2020;15:e0233980.
    PubMed     Abstract available

  95. VIAR K, Njoku D, Secor McVoy J, Oh U, et al
    Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
    PLoS One. 2020;15:e0235110.
    PubMed     Abstract available

  96. JI H, Godsland I, Oliver NS, Hill NE, et al
    Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
    PLoS One. 2020;15:e0234319.
    PubMed     Abstract available

  97. KEMMERER CL, Pernpeintner V, Ruschil C, Abdelhak A, et al
    Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
    PLoS One. 2020;15:e0235449.
    PubMed     Abstract available

  98. CHERAGHMAKANI H, Baghbanian SM, HabibiSaravi R, Azar A, et al
    Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
    PLoS One. 2020;15:e0235562.
    PubMed     Abstract available

  99. JIANG K, Kessler H, Park Y, Sudman M, et al
    Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.
    PLoS One. 2020;15:e0235857.
    PubMed     Abstract available

  100. JEON HS, Lee SM, Jung YM, Oh S, et al
    Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
    PLoS One. 2020;15:e0235838.
    PubMed     Abstract available

  101. VON BORSTEL A, Abdulahad WH, Dekkema G, Rutgers A, et al
    Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    PLoS One. 2020;15:e0235743.
    PubMed     Abstract available

  102. ROTSTEIN DL, Marrie RA, Tu K, Schultz SE, et al
    Health service utilization in immigrants with multiple sclerosis.
    PLoS One. 2020;15:e0234876.
    PubMed     Abstract available

  103. ILJICSOV A, Milanovich D, Ajtay A, Oberfrank F, et al
    Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
    PLoS One. 2020;15:e0236432.
    PubMed     Abstract available

  104. FARCI R, Carta A, Cocco E, Frau J, et al
    Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study.
    PLoS One. 2020;15:e0236090.
    PubMed     Abstract available

  105. MALDINEY T, Greigert H, Martin L, Benoit E, et al
    Full-field optical coherence tomography for the diagnosis of giant cell arteritis.
    PLoS One. 2020;15:e0234165.
    PubMed     Abstract available

  106. ZHAI Y, Liu Y, Qi Y, Long X, et al
    The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy.
    PLoS One. 2020;15:e0234492.
    PubMed     Abstract available

  107. CAVERZASI E, Cordano C, Zhu AH, Zhao C, et al
    Imaging correlates of visual function in multiple sclerosis.
    PLoS One. 2020;15:e0235615.
    PubMed     Abstract available

  108. CHEN CH, Wu MJ, Wen MC, Tsai SF, et al
    Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy.
    PLoS One. 2020;15:e0237075.
    PubMed     Abstract available

  109. MANION KP, Baglaenko Y, Chang NH, Talaei N, et al
    Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in Vkappa8/3H9 lupus-prone mice.
    PLoS One. 2020;15:e0236664.
    PubMed     Abstract available

  110. MARCHINI GS, Cestari IN, Salemi VMC, Irigoyen MC, et al
    Early changes in myocyte contractility and cardiac function in streptozotocin-induced type 1 diabetes in rats.
    PLoS One. 2020;15:e0237305.
    PubMed     Abstract available

  111. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    PubMed     Abstract available

  112. BYEON HJ, Kim JY, Ko J, Lee EJ, et al
    Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    PLoS One. 2020;15:e0237015.
    PubMed     Abstract available

  113. OPARA CN, Akintorin M, Byrd A, Cirignani N, et al
    Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g.
    PLoS One. 2020;15:e0236639.
    PubMed     Abstract available

  114. COBO-CALVO A, Ruiz A, Richard C, Blondel S, et al
    Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
    PLoS One. 2020;15:e0238301.
    PubMed     Abstract available

  115. SINHA S, Renavikar PS, Crawford MP, Steward-Tharp SM, et al
    Altered expression of SIRPgamma on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells.
    PLoS One. 2020;15:e0238070.
    PubMed     Abstract available

  116. ALTAMIRANO-BUSTAMANTE NF, Garrido-Magana E, Moran E, Calderon A, et al
    Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early beta-cell damage in obesity and diabetes.
    PLoS One. 2020;15:e0237667.
    PubMed     Abstract available

  117. REED JC, Preston-Hurlburt P, Philbrick W, Betancur G, et al
    The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
    PLoS One. 2020;15:e0236921.
    PubMed     Abstract available

  118. DEWAN K, Berke GS, Chhetri DK
    Lessons learned from open laryngotracheal airway resection and primary anastomosis in high risk patients.
    PLoS One. 2020;15:e0238426.
    PubMed     Abstract available

  119. SOUZA KM, Diniz IM, Lemos LLP, Junior NGR, et al
    Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
    PLoS One. 2020;15:e0238476.
    PubMed     Abstract available

  120. ZVIZDIC Z, Kovacevic A, Milisic E, Jonuzi A, et al
    Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.
    PLoS One. 2020;15:e0237016.
    PubMed     Abstract available

  121. CUBILLOS-ANGULO JM, Vinhaes CL, Fukutani ER, Albuquerque VVS, et al
    In silico transcriptional analysis of mRNA and miRNA reveals unique biosignatures that characterizes different types of diabetes.
    PLoS One. 2020;15:e0239061.
    PubMed     Abstract available

  122. RADWAN S, Gilfillan D, Eklund B, Radwan HM, et al
    A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
    PLoS One. 2020;15:e0238764.
    PubMed     Abstract available

  123. ALNAJASHI H, Jabbad R
    Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
    PLoS One. 2020;15:e0241103.
    PubMed     Abstract available

  124. BEREK K, Hegen H, Auer M, Zinganell A, et al
    Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi.
    PLoS One. 2020;15:e0239453.
    PubMed     Abstract available

  125. MOSER O, Mueller A, Eckstein ML, Ziko H, et al
    Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
    PLoS One. 2020;15:e0239091.
    PubMed     Abstract available

  126. OSINSKI M, Mantaj U, Kedzia M, Gutaj P, et al
    Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus.
    PLoS One. 2020;15:e0237843.
    PubMed     Abstract available

  127. YOSHIDA M, Kondo K, Matsui N, Izumi Y, et al
    Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients.
    PLoS One. 2020;15:e0239756.
    PubMed     Abstract available

  128. POHLMANN D, Barth A, Macedo S, Pleyer U, et al
    The impact of impending / onset of vision loss on depression, anxiety, and vision-related quality of life in Birdshot-Retinochoroiditis and Serpiginous Choroiditis.
    PLoS One. 2020;15:e0239210.
    PubMed     Abstract available

  129. ONG JX, Kwan CC, Cicinelli MV, Fawzi AA, et al
    Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy.
    PLoS One. 2020;15:e0240064.
    PubMed     Abstract available

  130. HUANG SK, Huang CY, Lin CH, Cheng BW, et al
    Acute kidney injury is a common complication in children and adolescents hospitalized for diabetic ketoacidosis.
    PLoS One. 2020;15:e0239160.
    PubMed     Abstract available

  131. VAIDYA A, Kakizaki H, Takahashi Y
    Changes in horizontal strabismus after inferior rectus muscle recession with or without nasal transposition in thyroid eye disease: A retrospective, observational study.
    PLoS One. 2020;15:e0240019.
    PubMed     Abstract available

  132. DHAOUADI T, Abdellatif J, Trabelsi R, Gaied H, et al
    PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    PLoS One. 2020;15:e0240025.
    PubMed     Abstract available

  133. NEVES PDMM, Souza RA, Torres FM, Reis FA, et al
    Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.
    PLoS One. 2020;15:e0233199.
    PubMed     Abstract available

  134. MELNIKOV M, Sharanova S, Sviridova A, Rogovskii V, et al
    The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    PLoS One. 2020;15:e0240305.
    PubMed     Abstract available

  135. D'ALMEIDA OC, Violante IR, Quendera B, Moreno C, et al
    The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0240907.
    PubMed     Abstract available

  136. KUEHN JC, Meschede C, Helmstaedter C, Surges R, et al
    Adult-onset temporal lobe epilepsy suspicious for autoimmune pathogenesis: Autoantibody prevalence and clinical correlates.
    PLoS One. 2020;15:e0241289.
    PubMed     Abstract available

  137. PERLEJEWSKI K, Bukowska-Osko I, Rydzanicz M, Dzieciatkowski T, et al
    Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.
    PLoS One. 2020;15:e0240601.
    PubMed     Abstract available

  138. LIU L, Wang R, Ding H, Tian L, et al
    The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
    PLoS One. 2020;15:e0240942.
    PubMed     Abstract available

  139. BORCHERT C, Herman A, Roth M, Brooks AC, et al
    RNA sequencing of whole blood in dogs with primary immune-mediated hemolytic anemia (IMHA) reveals novel insights into disease pathogenesis.
    PLoS One. 2020;15:e0240975.
    PubMed     Abstract available

  140. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    PubMed     Abstract available

  141. COTTRELL L, Economos G, Evans C, Silber E, et al
    A realist review of advance care planning for people with multiple sclerosis and their families.
    PLoS One. 2020;15:e0240815.
    PubMed     Abstract available

  142. CHOI JY, Chin HJ, Lee H, Bae EH, et al
    Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.
    PLoS One. 2020;15:e0240566.
    PubMed     Abstract available

  143. MOCHIZUKI M, Ito Y, Yokomichi H, Kikuchi T, et al
    Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort.
    PLoS One. 2020;15:e0242259.
    PubMed     Abstract available

  144. GROHOVA A, Danova K, Adkins I, Sumnik Z, et al
    Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
    PLoS One. 2020;15:e0242092.
    PubMed     Abstract available

  145. CORTEZ FJ, Gebhart D, Robinson PV, Seftel D, et al
    Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.
    PLoS One. 2020;15:e0242049.
    PubMed     Abstract available

  146. ZHANG X, Gao B, Xu B
    No association between the vitamin D-binding protein (DBP) gene polymorphisms (rs7041 and rs4588) and multiple sclerosis and type 1 diabetes mellitus: A meta-analysis.
    PLoS One. 2020;15:e0242256.
    PubMed     Abstract available

  147. KASHIWAKURA JI, Saitoh K, Ihara T, Sasaki Y, et al
    Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.
    PLoS One. 2020;15:e0241440.
    PubMed     Abstract available

  148. ABE K, Fujita M, Hayashi M, Takahashi A, et al
    Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.
    PLoS One. 2020;15:e0239481.
    PubMed     Abstract available

  149. AMADOU C, Denis P, Cosker K, Fagot-Campagna A, et al
    Less amputations for diabetic foot ulcer from 2008 to 2014, hospital management improved but substantial progress is still possible: A French nationwide study.
    PLoS One. 2020;15:e0242524.
    PubMed     Abstract available

  150. PERRAUDIN C, Bourdin A, Vicino A, Kuntzer T, et al
    Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
    PLoS One. 2020;15:e0242630.
    PubMed     Abstract available

  151. BASUALTO-ALARCON C, Urra FA, Bozan MF, Jana F, et al
    Idiopathic inflammatory myopathy human derived cells retain their ability to increase mitochondrial function.
    PLoS One. 2020;15:e0242443.
    PubMed     Abstract available

  152. MIGITA K, Nakamura M, Aiba Y, Kozuru H, et al
    Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
    PLoS One. 2020;15:e0238540.
    PubMed     Abstract available

  153. NIKOLIC B, Ivancevic N, Zaletel I, Rovcanin B, et al
    Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
    PLoS One. 2020;15:e0243031.
    PubMed     Abstract available

  154. DING M, Markon A, Wolpert B, Chavarro JE, et al
    Associations of body mass index and waist circumference with risk of Guillain-Barre syndrome in women and men: A prospective analysis of three cohort studies.
    PLoS One. 2020;15:e0239099.
    PubMed     Abstract available

  155. VICKARYOUS N, Jitlal M, Jacobs BM, Middleton R, et al
    Remote testing of vitamin D levels across the UK MS population-A case control study.
    PLoS One. 2020;15:e0241459.
    PubMed     Abstract available

  156. AFAA TJ, Amegan-Aho KH, Dono MT, Odei E, et al
    Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
    PLoS One. 2020;15:e0239964.
    PubMed     Abstract available

  157. SMAOUI MR, Rabasa-Lhoret R, Haidar A
    Development platform for artificial pancreas algorithms.
    PLoS One. 2020;15:e0243139.
    PubMed     Abstract available

  158. FREITAS DA, Souza-Santos R, Carvalho LMA, Barros WB, et al
    Congenital Zika syndrome: A systematic review.
    PLoS One. 2020;15:e0242367.
    PubMed     Abstract available

  159. CORDON B, Vilades E, Orduna E, Satue M, et al
    Angiography with optical coherence tomography as a biomarker in multiple sclerosis.
    PLoS One. 2020;15:e0243236.
    PubMed     Abstract available

  160. TANAKA H, Yamaguchi M, Katsuno T, Sugiyama H, et al
    Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.
    PLoS One. 2020;15:e0243572.
    PubMed     Abstract available

  161. ZOPPINI G, Bergamini C, Trombetta M, Mantovani A, et al
    Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes.
    PLoS One. 2020;15:e0244483.
    PubMed     Abstract available

    January 2019
  162. OCANA GJ, Sims EK, Watkins RA, Ragg S, et al
    Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes.
    PLoS One. 2019;14:e0208456.
    PubMed     Abstract available

  163. KOBELT G, Teich V, Cavalcanti M, Canzonieri AM, et al
    Burden and cost of multiple sclerosis in Brazil.
    PLoS One. 2019;14:e0208837.
    PubMed     Abstract available

  164. ROONEY NJ, Guest CM, Swanson LCM, Morant SV, et al
    How effective are trained dogs at alerting their owners to changes in blood glycaemic levels?: Variations in performance of glycaemia alert dogs.
    PLoS One. 2019;14:e0210092.
    PubMed     Abstract available

  165. FRAHM N, Hecker M, Zettl UK
    Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.
    PLoS One. 2019;14:e0211120.
    PubMed     Abstract available

  166. PELLEGRINO M, Crino A, Rosado MM, Fierabracci A, et al
    Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients.
    PLoS One. 2019;14:e0210839.
    PubMed     Abstract available

  167. WORMSBECKER AE, Johnson C, Bourns L, Harris T, et al
    Demonstration of background rates of three conditions of interest for vaccine safety surveillance.
    PLoS One. 2019;14:e0210833.
    PubMed     Abstract available

  168. LI YJ, Wu HH, Liu SH, Tu KH, et al
    Polyomavirus BK, BKV microRNA, and urinary neutrophil gelatinase-associated lipocalin can be used as potential biomarkers of lupus nephritis.
    PLoS One. 2019;14:e0210633.
    PubMed     Abstract available

  169. DUQUETTE P, Yeung M, Mouallif S, Nakhaipour HR, et al
    A retrospective claims analysis: Compliance and discontinuation rates among Canadian patients with multiple sclerosis treated with disease-modifying therapies.
    PLoS One. 2019;14:e0210417.
    PubMed     Abstract available

  170. BRAFFETT BH, Rice MM, Young HA, Lachin JM, et al
    Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
    PLoS One. 2019;14:e0210367.
    PubMed     Abstract available

  171. LI X, He L, Wang J, Wang M, et al
    Illness uncertainty, social support, and coping mode in hospitalized patients with systemic lupus erythematosus in a hospital in Shaanxi, China.
    PLoS One. 2019;14:e0211313.
    PubMed     Abstract available

  172. LIAO D, Ma L, Liu J, Fu P, et al
    Cigarette smoking as a risk factor for diabetic nephropathy: A systematic review and meta-analysis of prospective cohort studies.
    PLoS One. 2019;14:e0210213.
    PubMed     Abstract available

  173. PEARSALL EA, Cheng R, Matsuzaki S, Zhou K, et al
    Neuroprotective effects of PPARalpha in retinopathy of type 1 diabetes.
    PLoS One. 2019;14:e0208399.
    PubMed     Abstract available

  174. YEOW TP, Aun ES, Hor CP, Lim SL, et al
    Challenges in the classification and management of Asian youth-onset diabetes mellitus- lessons learned from a single centre study.
    PLoS One. 2019;14:e0211210.
    PubMed     Abstract available

  175. KITAMURA M, Obata Y, Ota Y, Muta K, et al
    Significance of subepithelial deposits in patients diagnosed with IgA nephropathy.
    PLoS One. 2019;14:e0211812.
    PubMed     Abstract available

  176. SCHMIDT P, Kempin R, Langner S, Beule A, et al
    Association of anthropometric markers with globe position: A population-based MRI study.
    PLoS One. 2019;14:e0211817.
    PubMed     Abstract available

  177. HESSELS AC, van der Hoeven JH, Sanders JSF, Brouwer E, et al
    Leg muscle strength is reduced and is associated with physical quality of life in Antineutrophil cytoplasmic antibody-associated vasculitis.
    PLoS One. 2019;14:e0211895.
    PubMed     Abstract available

  178. MAIXNEROVA D, Ling C, Hall S, Reily C, et al
    Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
    PLoS One. 2019;14:e0212254.
    PubMed     Abstract available

  179. LANG SN, Germerodt S, Glock C, Skerka C, et al
    Molecular crypsis by pathogenic fungi using human factor H. A numerical model.
    PLoS One. 2019;14:e0212187.
    PubMed     Abstract available

  180. CARTER KL, Treurnicht A, Davis KL, Kumar RB, et al
    A novel platform for isotype-specific testing of autoantibodies.
    PLoS One. 2019;14:e0211596.
    PubMed     Abstract available

  181. DE OLIVEIRA AR, da Silva FS, Bortolin RH, Marques DEDS, et al
    Effect of photobiomodulation and exercise on early remodeling of the Achilles tendon in streptozotocin-induced diabetic rats.
    PLoS One. 2019;14:e0211643.
    PubMed     Abstract available

  182. BIGAUT K, Achard S, Hemmert C, Baloglu S, et al
    Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).
    PLoS One. 2019;14:e0211465.
    PubMed     Abstract available

  183. KALTSONOUDIS E, Pelechas E, Papoudou-Bai A, Markatseli TE, et al
    The impact of temporal artery biopsy for the diagnosis of giant cell arteritis in clinical practice in a tertiary university hospital.
    PLoS One. 2019;14:e0210845.
    PubMed     Abstract available

  184. LINDHOLM E, Londahl M, Fagher K, Apelqvist J, et al
    Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers.
    PLoS One. 2019;14:e0212921.
    PubMed     Abstract available

  185. DUCHATEAU L, Martin-Aguilar L, Lleixa C, Cortese A, et al
    Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy.
    PLoS One. 2019;14:e0212647.
    PubMed     Abstract available

  186. VAN LEEUWEN N, Walgaard C, van Doorn PA, Jacobs BC, et al
    Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barre syndrome.
    PLoS One. 2019;14:e0211404.
    PubMed     Abstract available

  187. LEE S, Salapa HE, Levin MC
    Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis.
    PLoS One. 2019;14:e0212357.
    PubMed     Abstract available

  188. VAN DER DONK LJ, Fleer J, Sanderman R, Emmelkamp PMG, et al
    Is type of depressive symptoms associated with patient-perceived need for professional psychological care in depressed individuals with diabetes?
    PLoS One. 2019;14:e0212304.
    PubMed     Abstract available

  189. MIRANDA S, Billoir P, Damian L, Thiebaut PA, et al
    Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction.
    PLoS One. 2019;14:e0212614.
    PubMed     Abstract available

  190. PARK DW, Lee YJ, Chang W, Park JH, et al
    Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease.
    PLoS One. 2019;14:e0212771.
    PubMed     Abstract available

  191. PARODIS I, Ding H, Zickert A, Cosson G, et al
    Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
    PLoS One. 2019;14:e0212068.
    PubMed     Abstract available

  192. SHAPSON-COE A, Valeiras B, Wall C, Rada C, et al
    Aicardi-Goutieres Syndrome associated mutations of RNase H2B impair its interaction with ZMYM3 and the CoREST histone-modifying complex.
    PLoS One. 2019;14:e0213553.
    PubMed     Abstract available

  193. WEI F, Xu H, Yan C, Rong C, et al
    Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China.
    PLoS One. 2019;14:e0213063.
    PubMed     Abstract available

  194. GIROLAMO F, Errede M, Longo G, Annese T, et al
    Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
    PLoS One. 2019;14:e0213508.
    PubMed     Abstract available

  195. EIDEN S, Beck C, Venhoff N, Elsheikh S, et al
    High-resolution contrast-enhanced vessel wall imaging in patients with suspected cerebral vasculitis: Prospective comparison of whole-brain 3D T1 SPACE versus 2D T1 black blood MRI at 3 Tesla.
    PLoS One. 2019;14:e0213514.
    PubMed     Abstract available

  196. ANDERSON K, Carey B, Martin A, Roark C, et al
    Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association.
    PLoS One. 2019;14:e0213179.
    PubMed     Abstract available

  197. PATRICK S, Connick P
    Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.
    PLoS One. 2019;14:e0197943.
    PubMed     Abstract available

  198. AZAMI M, YektaKooshali MH, Shohani M, Khorshidi A, et al
    Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0214738.
    PubMed     Abstract available

  199. KAIHAN AB, Yasuda Y, Imaizumi T, Inagaki K, et al
    Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.
    PLoS One. 2019;14:e0214414.
    PubMed     Abstract available

  200. ATKINSON MA, Joo S, Sule S
    Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: A cross-sectional study.
    PLoS One. 2019;14:e0214248.
    PubMed     Abstract available

  201. BAGCHI S, Lingaiah R, Mani K, Barwad A, et al
    Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
    PLoS One. 2019;14:e0214256.
    PubMed     Abstract available

  202. LEE SU, Li CF, Mortales CL, Pawling J, et al
    Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (TH1)/TH17 responses and autoimmunity.
    PLoS One. 2019;14:e0214253.
    PubMed     Abstract available

  203. VAZQUEZ-MATEO C, Collins J, Goldberg SJ, Lawson M, et al
    Combining anti-IL-7Ralpha antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
    PLoS One. 2019;14:e0214379.
    PubMed     Abstract available

  204. KAGEYAMA T, Furuta S, Ikeda K, Kagami SI, et al
    Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases.
    PLoS One. 2019;14:e0214324.
    PubMed     Abstract available

  205. LEE J, An JN, Hwang JH, Lee H, et al
    p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.
    PLoS One. 2019;14:e0213981.
    PubMed     Abstract available

  206. SHIRIN A, Della Rossa F, Klickstein I, Russell J, et al
    Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
    PLoS One. 2019;14:e0213665.
    PubMed     Abstract available

  207. LARDINOIS OM, Deterding LJ, Hess JJ, Poulton CJ, et al
    Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
    PLoS One. 2019;14:e0213215.
    PubMed     Abstract available

  208. NEATE SL, Taylor KL, Jelinek GA, De Livera AM, et al
    Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.
    PLoS One. 2019;14:e0212422.
    PubMed     Abstract available

  209. GAVILAN-CARRERA B, Garcia da Silva J, Vargas-Hitos JA, Sabio JM, et al
    Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity.
    PLoS One. 2019;14:e0212436.
    PubMed     Abstract available

  210. ABDULLAH A, Maged M, Hairul-Islam M I, Osama I A, et al
    Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
    PLoS One. 2019;14:e0215981.
    PubMed     Abstract available

  211. KONG Y, Rastogi D, Seoighe C, Greally JM, et al
    Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data.
    PLoS One. 2019;14:e0215987.
    PubMed     Abstract available

  212. LI S, Cao Y, Li L, Zhang H, et al
    Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.
    PLoS One. 2019;14:e0214857.
    PubMed     Abstract available

  213. HOGESTOL EA, Nygaard GO, Alnaes D, Beyer MK, et al
    Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis.
    PLoS One. 2019;14:e0210375.
    PubMed     Abstract available

  214. SCHIERLOH U, Wilinska ME, Pit-Ten Cate IM, Baumann P, et al
    Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial.
    PLoS One. 2019;14:e0212013.
    PubMed     Abstract available

  215. TEMPLETON N, Kivell B, McCaughey-Chapman A, Connor B, et al
    Clozapine administration enhanced functional recovery after cuprizone demyelination.
    PLoS One. 2019;14:e0216113.
    PubMed     Abstract available

  216. PEREZ DEL PALOMAR A, Cegonino J, Montolio A, Orduna E, et al
    Swept source optical coherence tomography to early detect multiple sclerosis disease. The use of machine learning techniques.
    PLoS One. 2019;14:e0216410.
    PubMed     Abstract available

  217. TAKASHI Y, Ishizu M, Mori H, Miyashita K, et al
    Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes.
    PLoS One. 2019;14:e0216416.
    PubMed     Abstract available

  218. BIKBOV MM, Fayzrakhmanov RR, Kazakbaeva GM, Zainullin RM, et al
    Prevalence, awareness and control of diabetes in Russia: The Ural Eye and Medical Study on adults aged 40+ years.
    PLoS One. 2019;14:e0215636.
    PubMed     Abstract available

  219. O'ROURKE JA, Ravichandran C, Howe YJ, Mullett JE, et al
    Accuracy of self-reported history of autoimmune disease: A pilot study.
    PLoS One. 2019;14:e0216526.
    PubMed     Abstract available

  220. LACKNER J, Weiss M, Muller-Graf C, Greiner M, et al
    The disease burden associated with Campylobacter spp. in Germany, 2014.
    PLoS One. 2019;14:e0216867.
    PubMed     Abstract available

  221. ALOWAYESH MS, Ahmed SF, Al-Hashel J, Alroughani R, et al
    Economic burden of multiple sclerosis on Kuwait health care system.
    PLoS One. 2019;14:e0216646.
    PubMed     Abstract available

  222. DE SANTIAGO L, Sanchez Morla EM, Ortiz M, Lopez E, et al
    A computer-aided diagnosis of multiple sclerosis based on mfVEP recordings.
    PLoS One. 2019;14:e0214662.
    PubMed     Abstract available

  223. BEDRI SK, Nilsson OB, Fink K, Manberg A, et al
    Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.
    PLoS One. 2019;14:e0217208.
    PubMed     Abstract available

  224. JIMENEZ VERA E, Chew YV, Nicholson L, Burns H, et al
    Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.
    PLoS One. 2019;14:e0217163.
    PubMed     Abstract available

  225. SHIN DH, Baek IC, Kim HJ, Choi EJ, et al
    HLA alleles, especially amino-acid signatures of HLA-DPB1, might contribute to the molecular pathogenesis of early-onset autoimmune thyroid disease.
    PLoS One. 2019;14:e0216941.
    PubMed     Abstract available

  226. THORNTON SNIDER J, Sullivan J, van Eijndhoven E, Hansen MK, et al
    Lifetime benefits of early detection and treatment of diabetic kidney disease.
    PLoS One. 2019;14:e0217487.
    PubMed     Abstract available

  227. EVDOSHENKO E, Stepanova A, Shumilina M, Davydovskaya M, et al
    Real-world study of efficacy, risk management and reasons for discontinuation of natalizumab for treatment of multiple sclerosis in Russia.
    PLoS One. 2019;14:e0217303.
    PubMed     Abstract available

  228. ZHANG Y, Welzig CM, Haburcak M, Wang B, et al
    Targeted disruption of glycogen synthase kinase-3beta in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice.
    PLoS One. 2019;14:e0215213.
    PubMed     Abstract available

  229. ZHANG W, Rho JH, Roehrl MW, Roehrl MH, et al
    A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins.
    PLoS One. 2019;14:e0219018.
    PubMed     Abstract available

  230. NAVARRO QUIROZ E, Navarro Quiroz R, Pacheco Lugo L, Aroca Martinez G, et al
    Integrated analysis of microRNA regulation and its interaction with mechanisms of epigenetic regulation in the etiology of systemic lupus erythematosus.
    PLoS One. 2019;14:e0218116.
    PubMed     Abstract available

  231. ROSNER B, Roman-Urrestarazu A
    Health-related quality of life in paediatric patients with Type 1 diabetes mellitus using insulin infusion systems. A systematic review and meta-analysis.
    PLoS One. 2019;14:e0217655.
    PubMed     Abstract available

  232. OHLSSON S, Holm L, Hansson C, Ohlsson SM, et al
    Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
    PLoS One. 2019;14:e0218272.
    PubMed     Abstract available

  233. MARRIE RA, O'Mahony J, Maxwell CJ, Ling V, et al
    High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.
    PLoS One. 2019;14:e0218215.
    PubMed     Abstract available

  234. UEKI M, Fujihara J, Kimura-Kataoka K, Yamada K, et al
    Low genetic heterogeneity of copy number variations (CNVs) in the genes encoding the human deoxyribonucleases 1-like 3 and II potentially relevant to autoimmunity.
    PLoS One. 2019;14:e0215479.
    PubMed     Abstract available

  235. RESALAT N, El Youssef J, Tyler N, Castle J, et al
    A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model.
    PLoS One. 2019;14:e0217301.
    PubMed     Abstract available

  236. RO LS, Yang CC, Lyu RK, Lin KP, et al
    A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan.
    PLoS One. 2019;14:e0202453.
    PubMed     Abstract available

  237. MORISHITA M, Sada KE, Matsumoto Y, Hayashi K, et al
    Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    PLoS One. 2019;14:e0218705.
    PubMed     Abstract available

  238. PETRETTO A, Bruschi M, Pratesi F, Croia C, et al
    Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis.
    PLoS One. 2019;14:e0218946.
    PubMed     Abstract available

  239. LANDTBLOM AM, Guala D, Martin C, Olsson-Hau S, et al
    RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif.
    PLoS One. 2019;14:e0218453.
    PubMed     Abstract available

  240. OEVERHAUS M, Copei A, Mattheis S, Ringelstein A, et al
    Influence of orbital morphology on proptosis reduction and ocular motility after decompression surgery in patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0218701.
    PubMed     Abstract available

  241. MANUWALD U, Schoffer O, Hegewald J, Grosse J, et al
    Ketoacidosis at onset of type 1 diabetes in children up to 14 years of age and the changes over a period of 18 years in Saxony, Eastern-Germany: A population based register study.
    PLoS One. 2019;14:e0218807.
    PubMed     Abstract available

  242. FELLOWS MAXWELL K, Wahls T, Browne RW, Rubenstein L, et al
    Lipid profile is associated with decreased fatigue in individuals with progressive multiple sclerosis following a diet-based intervention: Results from a pilot study.
    PLoS One. 2019;14:e0218075.
    PubMed     Abstract available

  243. GRIMALDI AE, De Giglio L, Haggiag S, Bianco A, et al
    The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
    PLoS One. 2019;14:e0219670.
    PubMed     Abstract available

  244. THALER MA, Bietenbeck A, Steigerwald U, Buttner T, et al
    Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs.
    PLoS One. 2019;14:e0220033.
    PubMed     Abstract available

  245. UCHI SH, Yanai R, Kobayashi M, Hatano M, et al
    Dendritic cells mediate the anti-inflammatory action of omega-3 long-chain polyunsaturated fatty acids in experimental autoimmune uveitis.
    PLoS One. 2019;14:e0219405.
    PubMed     Abstract available

  246. LOPEZ-MORAL M, Lazaro-Martinez JL, Garcia-Morales E, Garcia-Alvarez Y, et al
    Clinical efficacy of therapeutic footwear with a rigid rocker sole in the prevention of recurrence in patients with diabetes mellitus and diabetic polineuropathy: A randomized clinical trial.
    PLoS One. 2019;14:e0219537.
    PubMed     Abstract available

  247. KYVSGAARD N, Mikkelsen TS, Thastum M, Christensen AE, et al
    Increased methotrexate intolerance in juvenile idiopathic arthritis compared to acute lymphoblastic leukaemia in children.
    PLoS One. 2019;14:e0219539.
    PubMed     Abstract available

  248. KURANO M, Yatomi Y
    Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice.
    PLoS One. 2019;14:e0219403.
    PubMed     Abstract available

  249. KIM DH, Kim DW, Park JY, Lee YJ, et al
    Ultrasound detection of incidental diffuse parotid disease: A single-center study.
    PLoS One. 2019;14:e0219308.
    PubMed     Abstract available

  250. ZHENG X, Zhang Y, Yue P, Liu L, et al
    Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.
    PLoS One. 2019;14:e0217523.
    PubMed     Abstract available

  251. MAHMUD M, Pinnschmidt HO, Reinhard L, Harendza S, et al
    Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
    PLoS One. 2019;14:e0221293.
    PubMed     Abstract available

  252. HAREL Y, Kalron A, Menascu S, Magalashvili D, et al
    Cognitive function in multiple sclerosis: A long-term look on the bright side.
    PLoS One. 2019;14:e0221784.
    PubMed     Abstract available

  253. CUI J, Yan W, Xie H, Xu S, et al
    Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience.
    PLoS One. 2019;14:e0221793.
    PubMed     Abstract available

  254. CURRIE CJ, Berni ER, Berni TR, Jenkins-Jones S, et al
    Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.
    PLoS One. 2019;14:e0221044.
    PubMed     Abstract available

  255. ISMAILOVA K, Poudel P, Parlesak A, Frederiksen P, et al
    Vitamin D in early life and later risk of multiple sclerosis-A systematic review, meta-analysis.
    PLoS One. 2019;14:e0221645.
    PubMed     Abstract available

  256. YANG WL, Bose B, Zhang L, Mcstea M, et al
    Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    PLoS One. 2019;14:e0221531.
    PubMed     Abstract available

  257. JANG SY, Chae MK, Lee JH, Lee EJ, et al
    MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
    PLoS One. 2019;14:e0221077.
    PubMed     Abstract available

  258. ZHANG G, Bogdanova N, Gao T, Sheikh KA, et al
    Elimination of activating Fcgamma receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease.
    PLoS One. 2019;14:e0220250.
    PubMed     Abstract available

  259. SUGIMOTO M, Kondo M, Kamimoto Y, Ikeda T, et al
    Changes in VEGF-related factors are associated with presence of inflammatory factors in carbohydrate metabolism disorders during pregnancy.
    PLoS One. 2019;14:e0220650.
    PubMed     Abstract available

  260. STANGOU M, Marinaki S, Papachristou E, Kolovou K, et al
    Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
    PLoS One. 2019;14:e0217116.
    PubMed     Abstract available

  261. OBRISCA B, Stefan G, Gherghiceanu M, Mandache E, et al
    "Associated" or "Secondary" IgA nephropathy? An outcome analysis.
    PLoS One. 2019;14:e0221014.
    PubMed     Abstract available

  262. WALTEROS DM, Soares J, Styczynski AR, Abrams JY, et al
    Long-term outcomes of Guillain-Barre syndrome possibly associated with Zika virus infection.
    PLoS One. 2019;14:e0220049.
    PubMed     Abstract available

  263. URRUTIA I, Martinez R, Rica I, Martinez de LaPiscina I, et al
    Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?
    PLoS One. 2019;14:e0220634.
    PubMed     Abstract available

  264. LAVIA C, Couturier A, Erginay A, Dupas B, et al
    Reduced vessel density in the superficial and deep plexuses in diabetic retinopathy is associated with structural changes in corresponding retinal layers.
    PLoS One. 2019;14:e0219164.
    PubMed     Abstract available

  265. NASER AY, Wong ICK, Whittlesea C, Alwafi H, et al
    Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study.
    PLoS One. 2019;14:e0222275.
    PubMed     Abstract available

  266. AMATO MP, Prestipino E, Bellinvia A, Niccolai C, et al
    Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors.
    PLoS One. 2019;14:e0222929.
    PubMed     Abstract available

  267. TAKEI Y, Takahashi S, Nakasatomi M, Sakairi T, et al
    Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.
    PLoS One. 2019;14:e0223703.
    PubMed     Abstract available

  268. JONGEN PJ, van Mastrigt GA, Heerings M, Visser LH, et al
    Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial.
    PLoS One. 2019;14:e0223482.
    PubMed     Abstract available

  269. KISHI K, Kaji N, Kurosawa T, Aikiyo S, et al
    Hyperglycemia in the early stages of type 1 diabetes accelerates gastric emptying through increased networks of interstitial cells of Cajal.
    PLoS One. 2019;14:e0222961.
    PubMed     Abstract available

  270. SHAHARIR SS, Mohamed Said MS, Mohd R, Abdul Cader R, et al
    Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia.
    PLoS One. 2019;14:e0222343.
    PubMed     Abstract available

  271. MOCCIA M, Tajani A, Acampora R, Signoriello E, et al
    Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery.
    PLoS One. 2019;14:e0222012.
    PubMed     Abstract available

  272. GOOCH A, Zhang P, Hu Z, Loy Son N, et al
    Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776).
    PLoS One. 2019;14:e0218688.
    PubMed     Abstract available

  273. SHI J, Wu X, Chen Y
    Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis.
    PLoS One. 2019;14:e0222288.
    PubMed     Abstract available

  274. BUDA N, Masiak A, Zdrojewski Z
    Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement.
    PLoS One. 2019;14:e0222189.
    PubMed     Abstract available

  275. LUCIANO-JARAMILLO J, Sandoval-Garcia F, Vazquez-Del Mercado M, Gutierrez-Mercado YK, et al
    Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice.
    PLoS One. 2019;14:e0217190.
    PubMed     Abstract available

  276. LLAURADO G, Cano A, Albert L, Ballesta S, et al
    Arterial stiffness is highly correlated with the scores obtained from the Steno Type 1 Risk Engine in subjects with T1DM.
    PLoS One. 2019;14:e0220206.
    PubMed     Abstract available

  277. TASHIRO R, Niizuma K, Khor SS, Tokunaga K, et al
    Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.
    PLoS One. 2019;14:e0220858.
    PubMed     Abstract available

  278. EHLING R, Bsteh G, Muehlbacher A, Hermann K, et al
    Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.
    PLoS One. 2019;14:e0220613.
    PubMed     Abstract available

  279. GAJAMANGE S, Shelton A, Clough M, White O, et al
    Functional correlates of cognitive dysfunction in clinically isolated syndromes.
    PLoS One. 2019;14:e0219590.
    PubMed     Abstract available

  280. VAZQUEZ-MARRUFO M, Galvao-Carmona A, Caballero-Diaz R, Borges M, et al
    Altered individual behavioral and EEG parameters are related to the EDSS score in relapsing-remitting multiple sclerosis patients.
    PLoS One. 2019;14:e0219594.
    PubMed     Abstract available

  281. ZHANG L, Li Y, Lin X, Jia C, et al
    Liquid Chromatography/Mass Spectrometry based serum metabolomics study on recurrent abortion women with antiphospholipid syndrome.
    PLoS One. 2019;14:e0225463.
    PubMed     Abstract available

  282. BOQUETE L, Lopez-Guillen E, Vilades E, Miguel-Jimenez JM, et al
    Diagnostic ability of multifocal electroretinogram in early multiple sclerosis using a new signal analysis method.
    PLoS One. 2019;14:e0224500.
    PubMed     Abstract available

  283. SELVARAJA M, Abdullah M, Arip M, Chin VK, et al
    Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
    PLoS One. 2019;14:e0224707.
    PubMed     Abstract available

  284. STEINL DC, Xu L, Ochoa-Espinosa A, Punjabi M, et al
    Non-invasive contrast enhanced ultrasound molecular imaging of inflammation in autoimmune myocarditis for prediction of left ventricular fibrosis and remodeling.
    PLoS One. 2019;14:e0224377.
    PubMed     Abstract available

  285. KAPICA-TOPCZEWSKA K, Tarasiuk J, Collin F, Brola W, et al
    The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
    PLoS One. 2019;14:e0223863.
    PubMed     Abstract available

  286. HOLOHAN DR, Van Gool F, Bluestone JA
    Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
    PLoS One. 2019;14:e0217728.
    PubMed     Abstract available

  287. RYU J, Ryu H, Kim S, Chin HJ, et al
    Comparison of cancer prevalence between patients with glomerulonephritis and the general population at the time of kidney biopsy.
    PLoS One. 2019;14:e0224024.
    PubMed     Abstract available

  288. FISHER SA, Rahimzadeh M, Brierley C, Gration B, et al
    The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review.
    PLoS One. 2019;14:e0222313.
    PubMed     Abstract available

  289. ONDREJKOVA M, Jackuliak P, Martinka E, Mokan M, et al
    Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study.
    PLoS One. 2019;14:e0223788.
    PubMed     Abstract available

  290. ELSO CM, Scott NA, Mariana L, Masterman EI, et al
    Replacing murine insulin 1 with human insulin protects NOD mice from diabetes.
    PLoS One. 2019;14:e0225021.
    PubMed     Abstract available

  291. LI Y, Higgs RE, Hoffman RW, Dow ER, et al
    A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.
    PLoS One. 2019;14:e0225651.
    PubMed     Abstract available

  292. MAYO M, Chepulis L, Paul RG
    Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning.
    PLoS One. 2019;14:e0225613.
    PubMed     Abstract available

  293. JIANG N, Li M, Zhang M, Xu J, et al
    Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.
    PLoS One. 2019;14:e0225516.
    PubMed     Abstract available

  294. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    PubMed     Abstract available

  295. GROENER JB, Valkanou A, Kender Z, Pfeiffenberger J, et al
    Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
    PLoS One. 2019;14:e0222771.
    PubMed     Abstract available

  296. HAMMOND CL, Roztocil E, Phipps RP, Feldon SE, et al
    Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.
    PLoS One. 2019;14:e0222779.
    PubMed     Abstract available

  297. LIN SD, Butler JE, Boswell-Ruys CL, Hoang P, et al
    The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience.
    PLoS One. 2019;14:e0222731.
    PubMed     Abstract available

  298. BURKILL S, Vattulainen P, Geissbuehler Y, Sabido Espin M, et al
    The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    PLoS One. 2019;14:e0227120.
    PubMed     Abstract available

  299. PAN X, Kaminga AC, Wen SW, Acheampong K, et al
    Omentin-1 in diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226292.
    PubMed     Abstract available

  300. CORTINI A, Bembich S, Marson L, Cocco E, et al
    Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.
    PLoS One. 2019;14:e0226162.
    PubMed     Abstract available

  301. HAMMAD SM, Hardin JR, Wilson DA, Twal WO, et al
    Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    PLoS One. 2019;14:e0224496.
    PubMed     Abstract available

  302. CECCARELLI F, Pirone C, Mina C, Mascolo A, et al
    Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    PLoS One. 2019;14:e0224437.
    PubMed     Abstract available

  303. POSTIGO-ALONSO B, Galvao-Carmona A, Conde-Gavilan C, Jover A, et al
    The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.
    PLoS One. 2019;14:e0226775.
    PubMed     Abstract available

  304. MELIS M, Littera R, Cocco E, Frau J, et al
    Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    PLoS One. 2019;14:e0226615.
    PubMed     Abstract available

  305. EHLING R, Amprosi M, Kremmel B, Bsteh G, et al
    Second language learning induces grey matter volume increase in people with multiple sclerosis.
    PLoS One. 2019;14:e0226525.
    PubMed     Abstract available

    January 2018
  306. PLACZEK WJ, Yanagawa H, Makita Y, Renfrow MB, et al
    Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.
    PLoS One. 2018;13:e0190967.
    PubMed     Abstract available

  307. OZTURK MC, Xu Q, Cinar A
    Agent-based modeling of the interaction between CD8+ T cells and Beta cells in type 1 diabetes.
    PLoS One. 2018;13:e0190349.
    PubMed     Abstract available

  308. AGAH E, Zardoui A, Saghazadeh A, Ahmadi M, et al
    Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0190252.
    PubMed     Abstract available

  309. AKERMAN L, Casas R, Ludvigsson J, Tavira B, et al
    Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
    PLoS One. 2018;13:e0191067.
    PubMed     Abstract available

  310. WANG C, Klistorner A, Ly L, Barnett MH, et al
    White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques.
    PLoS One. 2018;13:e0191131.
    PubMed     Abstract available

  311. LAVTAR P, Rudolf G, Maver A, Hodzic A, et al
    Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.
    PLoS One. 2018;13:e0190601.
    PubMed     Abstract available

  312. MEMON AB, Javed A, Caon C, Srivastawa S, et al
    Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.
    PLoS One. 2018;13:e0190425.
    PubMed     Abstract available

  313. HENSCHEL AM, Cabrera SM, Kaldunski ML, Jia S, et al
    Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and beta-cell chemokine expression associated with autoimmune diabetes susceptibility.
    PLoS One. 2018;13:e0190351.
    PubMed     Abstract available

  314. DAHDAL S, Devetzis V, Chalikias G, Tziakas D, et al
    Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
    PLoS One. 2018;13:e0188695.
    PubMed     Abstract available

  315. SHIN S, Jung CH, Choi JY, Kwon HW, et al
    Long-term effects of pancreas transplant alone on nephropathy in type 1 diabetic patients with optimal renal function.
    PLoS One. 2018;13:e0191421.
    PubMed     Abstract available

  316. BEGGS CB, Giaquinta A, Veroux M, De Marco E, et al
    Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis.
    PLoS One. 2018;13:e0191534.
    PubMed     Abstract available

  317. BONNET-SERRANO F, Diedisheim M, Mallone R, Larger E, et al
    Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository.
    PLoS One. 2018;13:e0191528.
    PubMed     Abstract available

  318. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility.
    PLoS One. 2018;13:e0190043.
    PubMed     Abstract available

  319. HASSANI A, Corboy JR, Al-Salam S, Khan G, et al
    Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
    PLoS One. 2018;13:e0192109.
    PubMed     Abstract available

  320. LIMIRIO PHJO, da Rocha Junior HA, Morais RB, Hiraki KRN, et al
    Influence of hyperbaric oxygen on biomechanics and structural bone matrix in type 1 diabetes mellitus rats.
    PLoS One. 2018;13:e0191694.
    PubMed     Abstract available

  321. SIMEONOVIC CJ, Popp SK, Starrs LM, Brown DJ, et al
    Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.
    PLoS One. 2018;13:e0191360.
    PubMed     Abstract available

  322. CALOCER F, Dejardin O, Droulon K, Launoy G, et al
    Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients.
    PLoS One. 2018;13:e0191646.
    PubMed     Abstract available

  323. MUKHOPADHYAY N, Noble JA, Govil M, Marazita ML, et al
    Identifying genetic risk loci for diabetic complications and showing evidence for heterogeneity of type 1 diabetes based on complications risk.
    PLoS One. 2018;13:e0192696.
    PubMed     Abstract available

  324. ISLAM Z, Jahan I, Ahammad RU, Shahnaij M, et al
    FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barre syndrome.
    PLoS One. 2018;13:e0192703.
    PubMed     Abstract available

  325. DE FLON P, Soderstrom L, Laurell K, Dring A, et al
    Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls.
    PLoS One. 2018;13:e0192516.
    PubMed     Abstract available

  326. CASTOR T, Yogev N, Blank T, Barwig C, et al
    Inhibition of experimental autoimmune encephalomyelitis by tolerance-promoting DNA vaccination focused to dendritic cells.
    PLoS One. 2018;13:e0191927.
    PubMed     Abstract available

  327. DENNISON L, Brown M, Kirby S, Galea I, et al
    Do people with multiple sclerosis want to know their prognosis? A UK nationwide study.
    PLoS One. 2018;13:e0193407.
    PubMed     Abstract available

  328. POTTGEN J, Rose A, van de Vis W, Engelbrecht J, et al
    Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review.
    PLoS One. 2018;13:e0193381.
    PubMed     Abstract available

  329. WALLUKAT G, Pruss H, Muller J, Schimke I, et al
    Functional autoantibodies in patients with different forms of dementia.
    PLoS One. 2018;13:e0192778.
    PubMed     Abstract available

  330. RAHIMI F, Rasekh HR, Abbasian E, Peiravian F, et al
    Patient preferences for Interferon-beta in Iran: A discrete choice experiment.
    PLoS One. 2018;13:e0193090.
    PubMed     Abstract available

  331. BAGNATO F, Hametner S, Boyd E, Endmayr V, et al
    Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.
    PLoS One. 2018;13:e0193839.
    PubMed     Abstract available

  332. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Abstract available

  333. STOUSTRUP P, Iversen CK, Kristensen KD, Resnick CM, et al
    Assessment of dentofacial growth deviation in juvenile idiopathic arthritis: Reliability and validity of three-dimensional morphometric measures.
    PLoS One. 2018;13:e0194177.
    PubMed     Abstract available

  334. PARK KH, Waters P, Woodhall M, Lang B, et al
    Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    PLoS One. 2018;13:e0193723.
    PubMed     Abstract available

  335. KHAN A, Kamran S, Ponirakis G, Akhtar N, et al
    Peripheral neuropathy in patients with multiple sclerosis.
    PLoS One. 2018;13:e0193270.
    PubMed     Abstract available

  336. DRABORG AH, Rasmussen NS, Larsen JL, Jorgensen CS, et al
    Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    PLoS One. 2018;13:e0193244.
    PubMed     Abstract available

  337. GERASIMOU P, Nicolaidou V, Skordis N, Picolos M, et al
    Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.
    PLoS One. 2018;13:e0193684.
    PubMed     Abstract available

  338. CUI J, Yan W, Xu S, Wang Q, et al
    Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    PLoS One. 2018;13:e0193171.
    PubMed     Abstract available

  339. NARDIN C, Latarche C, Soudant M, Dahan C, et al
    Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.
    PLoS One. 2018;13:e0194115.
    PubMed     Abstract available

  340. HASLACHER H, Fallmann H, Waldhausl C, Hartmann E, et al
    Type 1 diabetes care: Improvement by standardization in a diabetes rehabilitation clinic. An observational report.
    PLoS One. 2018;13:e0194135.
    PubMed     Abstract available

  341. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus.
    PLoS One. 2018;13:e0193728.
    PubMed     Abstract available

  342. PONSONBY AL, Pezic A, Cameron FJ, Rodda C, et al
    Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices.
    PLoS One. 2018;13:e0193992.
    PubMed     Abstract available

  343. KOZIARSKA D, Krol J, Nocon D, Kubaszewski P, et al
    Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.
    PLoS One. 2018;13:e0194117.
    PubMed     Abstract available

  344. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    PubMed     Abstract available

  345. TURTON JL, Raab R, Rooney KB
    Low-carbohydrate diets for type 1 diabetes mellitus: A systematic review.
    PLoS One. 2018;13:e0194987.
    PubMed     Abstract available

  346. HOLM LJ, Haupt-Jorgensen M, Larsen J, Giacobini JD, et al
    L-serine supplementation lowers diabetes incidence and improves blood glucose homeostasis in NOD mice.
    PLoS One. 2018;13:e0194414.
    PubMed     Abstract available

  347. ANDROULIDAKI A, Wachsmuth L, Polykratis A, Pasparakis M, et al
    Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes.
    PLoS One. 2018;13:e0194048.
    PubMed     Abstract available

  348. KODA T, Namba A, Nakatsuji Y, Niino M, et al
    Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    PLoS One. 2018;13:e0193986.
    PubMed     Abstract available

  349. GARNIER AS, Duveau A, Demiselle J, Croue A, et al
    Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
    PLoS One. 2018;13:e0196101.
    PubMed     Abstract available

  350. MORILLAS-DE-LAGUNO P, Vargas-Hitos JA, Rosales-Castillo A, Saez-Uran LM, et al
    Association of objectively measured physical activity and sedentary time with arterial stiffness in women with systemic lupus erythematosus with mild disease activity.
    PLoS One. 2018;13:e0196111.
    PubMed     Abstract available

  351. KLISTORNER A, Wang C, Yiannikas C, Parratt J, et al
    Diffusivity in the core of chronic multiple sclerosis lesions.
    PLoS One. 2018;13:e0194142.
    PubMed     Abstract available

  352. FIGUEIREDO-BRAGA M, Cornaby C, Bernardes M, Figueiredo M, et al
    Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease.
    PLoS One. 2018;13:e0195579.
    PubMed     Abstract available

  353. MIZUGUCHI Y, Morimoto S, Kimura S, Takano N, et al
    Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    PLoS One. 2018;13:e0195464.
    PubMed     Abstract available

  354. NOVAKOVA L, Axelsson M, Malmestrom C, Imberg H, et al
    Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
    PLoS One. 2018;13:e0194828.
    PubMed     Abstract available

  355. MOSER O, Eckstein ML, McCarthy O, Deere R, et al
    Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes.
    PLoS One. 2018;13:e0194750.
    PubMed     Abstract available

  356. TAYLOR MEADOWS KR, Steinberg MW, Clemons B, Stokes ME, et al
    Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus.
    PLoS One. 2018;13:e0193236.
    PubMed     Abstract available

  357. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Schuster T, et al
    Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population.
    PLoS One. 2018;13:e0196244.
    PubMed     Abstract available

  358. UECHI E, Okada M, Fushimi K
    Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database.
    PLoS One. 2018;13:e0196009.
    PubMed     Abstract available

  359. ISING E, Dahlin LB, Elding Larsson H
    Impaired vibrotactile sense in children and adolescents with type 1 diabetes - Signs of peripheral neuropathy.
    PLoS One. 2018;13:e0196243.
    PubMed     Abstract available

  360. LARANJEIRA FO, de Andrade KRC, Figueiredo ACMG, Silva EN, et al
    Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials.
    PLoS One. 2018;13:e0194801.
    PubMed     Abstract available

  361. HESSELS AC, Rutgers A, Sanders JSF, Stegeman CA, et al
    Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.
    PLoS One. 2018;13:e0195524.
    PubMed     Abstract available

  362. KAWAI Y, Masutani K, Torisu K, Katafuchi R, et al
    Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent.
    PLoS One. 2018;13:e0196655.
    PubMed     Abstract available

  363. NWOSU BU, Zhang B, Ayyoub SS, Choi S, et al
    Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.
    PLoS One. 2018;13:e0196912.
    PubMed     Abstract available

  364. FERNANDEZ O, Izquierdo G, Fernandez V, Leyva L, et al
    Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
    PLoS One. 2018;13:e0195891.
    PubMed     Abstract available

  365. KRAAL LJN, Nijland ML, Germar KL, Baeten DLP, et al
    Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.
    PLoS One. 2018;13:e0197219.
    PubMed     Abstract available

  366. WITHER JE, Prokopec SD, Noamani B, Chang NH, et al
    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms.
    PLoS One. 2018;13:e0196117.
    PubMed     Abstract available

  367. HANAOKA H, Iida H, Kiyokawa T, Takakuwa Y, et al
    Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.
    PLoS One. 2018;13:e0196172.
    PubMed     Abstract available

  368. CECCARELLI F, Perricone C, Pirone C, Massaro L, et al
    Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
    PLoS One. 2018;13:e0196103.
    PubMed     Abstract available

  369. LIN Y, Liu L, Sheng Y, Shen C, et al
    A catalog of potential putative functional variants in psoriasis genome-wide association regions.
    PLoS One. 2018;13:e0196635.
    PubMed     Abstract available

  370. STORM FA, Nair KPS, Clarke AJ, Van der Meulen JM, et al
    Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    PLoS One. 2018;13:e0196463.
    PubMed     Abstract available

  371. DE SANTIAGO L, Sanchez-Morla E, Blanco R, Miguel JM, et al
    Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis.
    PLoS One. 2018;13:e0194964.
    PubMed     Abstract available

  372. CIURLEO R, Bonanno L, De Salvo S, Romeo L, et al
    Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study.
    PLoS One. 2018;13:e0196006.
    PubMed     Abstract available

  373. SANCHEZ-DALMAU B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, et al
    Predictors of vision impairment in Multiple Sclerosis.
    PLoS One. 2018;13:e0195856.
    PubMed     Abstract available

  374. MASUDA K, Tanabe K, Ujike H, Hinamoto N, et al
    Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    PLoS One. 2018;13:e0195779.
    PubMed     Abstract available

  375. DESHAYES S, Aouba A, Khoy K, Mariotte D, et al
    Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis.
    PLoS One. 2018;13:e0195680.
    PubMed     Abstract available

  376. WUERFEL E, Weddige A, Hagmayer Y, Jacob R, et al
    Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    PLoS One. 2018;13:e0194873.
    PubMed     Abstract available

  377. TAHVILI S, Torngren M, Holmberg D, Leanderson T, et al
    Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
    PLoS One. 2018;13:e0196598.
    PubMed     Abstract available

  378. MIKI A, Ricordi C, Sakuma Y, Yamamoto T, et al
    Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
    PLoS One. 2018;13:e0196570.
    PubMed     Abstract available

  379. DUARTE-GARCIA A, Romero-Diaz J, Juarez S, Cicero-Casarrubias A, et al
    Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
    PLoS One. 2018;13:e0196487.
    PubMed     Abstract available

  380. SCARR D, Lovblom LE, Cardinez N, Orszag A, et al
    Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    PLoS One. 2018;13:e0196647.
    PubMed     Abstract available

  381. CHROBOK NL, Bol JGJM, Jongenelen CA, Breve JJP, et al
    Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    PLoS One. 2018;13:e0196433.
    PubMed     Abstract available

    Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex.
    PLoS One. 2018;13:e0196277.
    PubMed     Abstract available

  383. MENDOZA-PINTO C, Rojas-Villarraga A, Molano-Gonzalez N, Jimenez-Herrera EA, et al
    Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.
    PLoS One. 2018;13:e0196113.
    PubMed     Abstract available

  384. MARCK CH, De Livera AM, Brown CR, Neate SL, et al
    Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up.
    PLoS One. 2018;13:e0197759.
    PubMed     Abstract available

  385. SCOTTI B, Disanto G, Sacco R, Guigli M, et al
    Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland.
    PLoS One. 2018;13:e0197415.
    PubMed     Abstract available

  386. YAMADA K, Zuka M, Ito K, Mizuguchi K, et al
    LatY136F knock-in mouse model for human IgG4-related disease.
    PLoS One. 2018;13:e0198417.
    PubMed     Abstract available

  387. WEIS CA, Aban IB, Cutter G, Kaminski HJ, et al
    Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
    PLoS One. 2018;13:e0197435.
    PubMed     Abstract available

  388. KUWABARA Y, Katayama A, Kurihara S, Orimo H, et al
    Immunoproteomic identification of anti-C9 autoimmune antibody in patients with seronegative obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198472.
    PubMed     Abstract available

  389. ZHANG J, Liang Y, Ai Y, Li X, et al
    Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis.
    PLoS One. 2018;13:e0198504.
    PubMed     Abstract available

  390. DEPRE F, Aboud N, Mayer B, Salama A, et al
    Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
    PLoS One. 2018;13:e0198184.
    PubMed     Abstract available

  391. PARKER HARP CR, Archambault AS, Sim J, Shlomchik MJ, et al
    B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis.
    PLoS One. 2018;13:e0199694.
    PubMed     Abstract available

  392. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Abstract available

  393. WILLERS C, Iderberg H, Axelsen M, Dahlstrom T, et al
    Sociodemographic determinants and health outcome variation in individuals with type 1 diabetes mellitus: A register-based study.
    PLoS One. 2018;13:e0199170.
    PubMed     Abstract available

  394. LANATA CM, Nititham J, Taylor KE, Chung SA, et al
    Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients.
    PLoS One. 2018;13:e0199003.
    PubMed     Abstract available

  395. HAIDER MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, et al
    Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.
    PLoS One. 2018;13:e0198652.
    PubMed     Abstract available

  396. BESSER REJ, Ludvigsson J, Hindmarsh PC, Cole TJ, et al
    Exploring C-peptide loss in type 1 diabetes using growth curve analysis.
    PLoS One. 2018;13:e0199635.
    PubMed     Abstract available

  397. HOZUMI H, Oyama Y, Yasui H, Suzuki Y, et al
    Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
    PLoS One. 2018;13:e0199659.
    PubMed     Abstract available

  398. LIANG D, Shao H, Born WK, O'Brien RL, et al
    High level expression of A2ARs is required for the enhancing function, but not for the inhibiting function, of gammadelta T cells in the autoimmune responses of EAU.
    PLoS One. 2018;13:e0199601.
    PubMed     Abstract available

  399. HACHICHA H, Mahfoudh N, Fourati H, Elloumi N, et al
    HLA Class III: A susceptibility region to systemic lupus erythematosus in Tunisian population.
    PLoS One. 2018;13:e0198549.
    PubMed     Abstract available

  400. GIOVANNETTI AM, Borreani C, Bianchi E, Giordano A, et al
    Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.
    PLoS One. 2018;13:e0200532.
    PubMed     Abstract available

  401. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Abstract available

  402. KARUPPAGOUNDER V, Bajpai A, Meng S, Arumugam S, et al
    Small molecule disruption of G protein betagamma subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.
    PLoS One. 2018;13:e0200697.
    PubMed     Abstract available

  403. ADUSUMILLI G, Lancia S, Levasseur VA, Amblee V, et al
    Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    PLoS One. 2018;13:e0198178.
    PubMed     Abstract available

  404. KERVINEN MH, Lehto S, Helve J, Gronhagen-Riska C, et al
    Type 2 diabetic patients on renal replacement therapy: Probability to receive renal transplantation and survival after transplantation.
    PLoS One. 2018;13:e0201478.
    PubMed     Abstract available

  405. CUMMINGS M, Arumanayagam ACS, Zhao P, Kannanganat S, et al
    Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0200752.
    PubMed     Abstract available

  406. CASANA-GRANELL S, Lacomba-Trejo L, Valero-Moreno S, Prado-Gasco V, et al
    A brief version of the Pediatric Inventory for Parents (PIP) in Spanish population: Stress of main family carers of chronic paediatric patients.
    PLoS One. 2018;13:e0201390.
    PubMed     Abstract available

  407. SAIRANEN E, Lappalainen P, Hiltunen A
    Psychological inflexibility explains distress in parents whose children have chronic conditions.
    PLoS One. 2018;13:e0201155.
    PubMed     Abstract available

  408. ZHERNAKOVA DV, Kliver S, Cherkasov N, Tamazian G, et al
    Analytical "bake-off" of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis.
    PLoS One. 2018;13:e0200423.
    PubMed     Abstract available

  409. VIEIRA A, Vergoni B, Courtney M, Druelle N, et al
    Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity.
    PLoS One. 2018;13:e0201536.
    PubMed     Abstract available

  410. KANG Y, Schlyer D, Kaunzner UW, Kuceyeski A, et al
    Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
    PLoS One. 2018;13:e0201289.
    PubMed     Abstract available

  411. MARTIN NA, Nawrocki A, Molnar V, Elkjaer ML, et al
    Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.
    PLoS One. 2018;13:e0202530.
    PubMed     Abstract available

  412. MOHN J, Igland J, Zoffmann V, Peyrot M, et al
    Factors explaining variation in self-esteem among persons with type 1 diabetes and elevated HbA1c.
    PLoS One. 2018;13:e0201006.
    PubMed     Abstract available

  413. LABAN S, Suwandi JS, van Unen V, Pool J, et al
    Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus.
    PLoS One. 2018;13:e0200818.
    PubMed     Abstract available

  414. NACKA-ALEKSIC M, Stojanovic M, Pilipovic I, Stojic-Vukanic Z, et al
    Strain differences in thymic atrophy in rats immunized for EAE correlate with the clinical outcome of immunization.
    PLoS One. 2018;13:e0201848.
    PubMed     Abstract available

  415. POPESCU DC, Huang H, Singhal NK, Shriver L, et al
    Vitamin K enhances the production of brain sulfatides during remyelination.
    PLoS One. 2018;13:e0203057.
    PubMed     Abstract available

  416. CHAWLA S, Kister I, Sinnecker T, Wuerfel J, et al
    Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging.
    PLoS One. 2018;13:e0202918.
    PubMed     Abstract available

  417. GONZALEZ-QUINTIAL R, Nguyen A, Kono DH, Oldstone MBA, et al
    Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition.
    PLoS One. 2018;13:e0203118.
    PubMed     Abstract available

  418. AGARWAL A, Hall RP 3rd, Banez LL, Cardones AR, et al
    Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
    PLoS One. 2018;13:e0198074.
    PubMed     Abstract available

  419. MALDONADO M, Buendia-Roldan I, Vicens-Zygmunt V, Planas L, et al
    Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    PLoS One. 2018;13:e0203779.
    PubMed     Abstract available

  420. SCHENKEIN HA, Thomas RR
    Anticardiolipin (aCL) in sera from periodontitis subjects activate Toll-like receptor 4 (TLR4).
    PLoS One. 2018;13:e0203494.
    PubMed     Abstract available

  421. SIOOFY-KHOJINE AB, Oikarinen S, Honkanen H, Huhtala H, et al
    Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes.
    PLoS One. 2018;13:e0201959.
    PubMed     Abstract available

  422. BURKARD T, Trendelenburg M, Daikeler T, Hess C, et al
    The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography.
    PLoS One. 2018;13:e0202105.
    PubMed     Abstract available

  423. PEJU M, Deroux A, Pelloux H, Bouillet L, et al
    Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation.
    PLoS One. 2018;13:e0204468.
    PubMed     Abstract available

  424. KRISTENSEN LJ, Birkebaek NH, Mose AH, Berg Jensen M, et al
    Multi-informant path models of the influence of psychosocial and treatment-related variables on adherence and metabolic control in adolescents with type 1 diabetes mellitus.
    PLoS One. 2018;13:e0204176.
    PubMed     Abstract available

  425. MOKHTARZADEH KHANGHAHI A, Satarian L, Deng W, Baharvand H, et al
    In vivo conversion of astrocytes into oligodendrocyte lineage cells with transcription factor Sox10; Promise for myelin repair in multiple sclerosis.
    PLoS One. 2018;13:e0203785.
    PubMed     Abstract available

  426. GRACIA F, Larreategui M, Rodriguez G, Benzadon A, et al
    Costs of multiple sclerosis in Panama from societal, patient perspectives and health-related quality of life.
    PLoS One. 2018;13:e0204681.
    PubMed     Abstract available

  427. TAKAHASHI A, Moriya K, Ohira H, Arinaga-Hino T, et al
    Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.
    PLoS One. 2018;13:e0204772.
    PubMed     Abstract available

  428. KALKOWSKI L, Malysz-Cymborska I, Golubczyk D, Janowski M, et al
    MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.
    PLoS One. 2018;13:e0204650.
    PubMed     Abstract available

  429. UGARTE-BERZAL E, Berghmans N, Boon L, Martens E, et al
    Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis.
    PLoS One. 2018;13:e0197944.
    PubMed     Abstract available

  430. SCHEIDLER AM, Kinnett-Hopkins D, Learmonth YC, Motl R, et al
    Targeted ballet program mitigates ataxia and improves balance in females with mild-to-moderate multiple sclerosis.
    PLoS One. 2018;13:e0205382.
    PubMed     Abstract available

  431. LASO-GARCIA F, Ramos-Cejudo J, Carrillo-Salinas FJ, Otero-Ortega L, et al
    Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis.
    PLoS One. 2018;13:e0202590.
    PubMed     Abstract available

  432. SVOLGAARD O, Andersen KW, Bauer C, Madsen KH, et al
    Cerebellar and premotor activity during a non-fatiguing grip task reflects motor fatigue in relapsing-remitting multiple sclerosis.
    PLoS One. 2018;13:e0201162.
    PubMed     Abstract available

  433. RHEE RL, Holweg CTJ, Wong K, Cuthbertson D, et al
    Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2018;13:e0205768.
    PubMed     Abstract available

  434. SENGUPTA M, Wang BD, Lee NH, Marx A, et al
    MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.
    PLoS One. 2018;13:e0205464.
    PubMed     Abstract available

  435. CHOI JY, Chung JE, Park JH, Cho YS, et al
    Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study.
    PLoS One. 2018;13:e0204573.
    PubMed     Abstract available

  436. GARAU M, Cabrera J, Ottati G, Caorsi H, et al
    Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014.
    PLoS One. 2018;13:e0206637.
    PubMed     Abstract available

  437. NOCITI V, Santoro M, Quaranta D, Losavio FA, et al
    BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
    PLoS One. 2018;13:e0206140.
    PubMed     Abstract available

  438. DIVINO V, Mallick R, DeKoven M, Krishnarajah G, et al
    The economic burden of CIDP in the United States: A case-control study.
    PLoS One. 2018;13:e0206205.
    PubMed     Abstract available

  439. MARTINEZ VALENZUELA L, Draibe J, Quero Ramos M, Fulladosa Oliveras X, et al
    Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis.
    PLoS One. 2018;13:e0205982.
    PubMed     Abstract available

  440. PENG Y
    B cell responses to apoptotic cells in MFG-E8-/- mice.
    PLoS One. 2018;13:e0205172.
    PubMed     Abstract available

  441. BARBOSA FB, Simioni M, Wiezel CEV, Torres FR, et al
    Copy number variation in the susceptibility to systemic lupus erythematosus.
    PLoS One. 2018;13:e0206683.
    PubMed     Abstract available

  442. CHU R, Kim G, Tauhid S, Khalid F, et al
    Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    PLoS One. 2018;13:e0206939.
    PubMed     Abstract available

  443. JEONG A, Min JH, Kang YK, Kim J, et al
    Factors associated with quality of life of people with Myasthenia Gravis.
    PLoS One. 2018;13:e0206754.
    PubMed     Abstract available

  444. KOHN JR, Hilliard ME, Lyons SK, Fox KA, et al
    Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes.
    PLoS One. 2018;13:e0206102.
    PubMed     Abstract available

  445. WADA Y, Matsumoto K, Suzuki T, Saito T, et al
    Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    PLoS One. 2018;13:e0206865.
    PubMed     Abstract available

  446. RHEAD B, Brorson IS, Berge T, Adams C, et al
    Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
    PLoS One. 2018;13:e0206511.
    PubMed     Abstract available

  447. SULLIVAN CA, Cacicedo JM, Rajendran I, Steenkamp DW, et al
    Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study.
    PLoS One. 2018;13:e0207065.
    PubMed     Abstract available

  448. MAIA DINIZ I, Guerra AA Junior, Lovato Pires de Lemos L, Souza KM, et al
    The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil.
    PLoS One. 2018;13:e0199446.
    PubMed     Abstract available

  449. PAWLITZKI M, Sweeney-Reed CM, Meuth SG, Reinhold D, et al
    CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
    PLoS One. 2018;13:e0207726.
    PubMed     Abstract available

  450. AUDIA S, Bach B, Samson M, Lakomy D, et al
    Venous thromboembolic events during warm autoimmune hemolytic anemia.
    PLoS One. 2018;13:e0207218.
    PubMed     Abstract available

  451. GIORDANO A, Liethmann K, Kopke S, Poettgen J, et al
    Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.
    PLoS One. 2018;13:e0208004.
    PubMed     Abstract available

  452. BHANDAGE AK, Jin Z, Korol SV, Tafreshiha AS, et al
    Expression of calcium release-activated and voltage-gated calcium channels genes in peripheral blood mononuclear cells is altered in pregnancy and in type 1 diabetes.
    PLoS One. 2018;13:e0208981.
    PubMed     Abstract available

  453. ADU MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS, et al
    Users' preferences and design recommendations to promote engagements with mobile apps for diabetes self-management: Multi-national perspectives.
    PLoS One. 2018;13:e0208942.
    PubMed     Abstract available

  454. GUARDIA-OLMOS J, Gudayol-Ferre E, Gallardo-Moreno GB, Martinez-Ricart M, et al
    Complex systems representing effective connectivity in patients with Type One diabetes mellitus.
    PLoS One. 2018;13:e0208247.
    PubMed     Abstract available

  455. PABALAN N, Tiongco RE, Pandac JK, Paragas NA, et al
    Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
    PLoS One. 2018;13:e0208905.
    PubMed     Abstract available

  456. KOSKIMAKI F, Bernard J, Yong J, Arndt N, et al
    Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
    PLoS One. 2018;13:e0209326.
    PubMed     Abstract available

    January 2017
  457. CHANNANATH AM, Elkum N, Al-Abdulrazzaq D, Tuomilehto J, et al
    Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.
    PLoS One. 2017;12:e0175728.
    PubMed     Abstract available

  458. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Abstract available

  459. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Abstract available

  460. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Abstract available

  461. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Abstract available

  462. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Abstract available

  463. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Abstract available

  464. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Abstract available

  465. KRAMER J, Tenberge JG, Kleiter I, Gaissmaier W, et al
    Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    PLoS One. 2017;12:e0174858.
    PubMed     Abstract available

  466. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Abstract available

  467. GUSTAFSSON JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, et al
    Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    PLoS One. 2017;12:e0174572.
    PubMed     Abstract available

  468. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Abstract available

  469. RAFFEL J, Gafson AR, Dahdaleh S, Malik O, et al
    Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
    PLoS One. 2017;12:e0169546.
    PubMed     Abstract available

  470. ZITTEMA D, Casteleijn NF, Bakker SJ, Boesten LS, et al
    Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    PLoS One. 2017;12:e0169263.
    PubMed     Abstract available

  471. KAVALIUNAS A, Manouchehrinia A, Danylaite Karrenbauer V, Gyllensten H, et al
    Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    PLoS One. 2017;12:e0169460.
    PubMed     Abstract available

  472. ATKILT HS, Turago MG, Tegegne BS
    Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169666.
    PubMed     Abstract available

  473. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Abstract available

  474. BONFIGLIO T, Olivero G, Merega E, Di Prisco S, et al
    Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2017;12:e0170825.
    PubMed     Abstract available

  475. YEUNG KS, Chung BH, Choufani S, Mok MY, et al
    Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    PLoS One. 2017;12:e0169553.
    PubMed     Abstract available

  476. BYTOFT B, Knorr S, Vlachova Z, Jensen RB, et al
    Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes.
    PLoS One. 2017;12:e0169308.
    PubMed     Abstract available

  477. URRUTIA I, Martinez R, Lopez-Euba T, Velayos T, et al
    Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.
    PLoS One. 2017;12:e0169389.
    PubMed     Abstract available

  478. HERNANDEZ-MIR G, McGeachy MJ
    CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.
    PLoS One. 2017;12:e0173655.
    PubMed     Abstract available

  479. MISTERSKA E, Kaminiarczyk-Pyzalka D, Adamczak K, Adamczyk KA, et al
    Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire.
    PLoS One. 2017;12:e0173768.
    PubMed     Abstract available

  480. PAPOTTO PH, Marengo EB, Sardinha LR, Carvalho KI, et al
    Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production.
    PLoS One. 2017;12:e0171822.
    PubMed     Abstract available

  481. KOMEGAE EN, Souza TA, Grund LZ, Lima C, et al
    Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0171796.
    PubMed     Abstract available

  482. MUNROE ME, Pezant N, Brown MA, Fife DA, et al
    Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.
    PLoS One. 2017;12:e0171193.
    PubMed     Abstract available

  483. TOFFOLI B, Gilardi F, Winkler C, Soderberg M, et al
    Nephropathy in Pparg-null mice highlights PPARgamma systemic activities in metabolism and in the immune system.
    PLoS One. 2017;12:e0171474.
    PubMed     Abstract available

  484. ZOU L, Wang H, Xiao Z, Fang Q, et al
    Tai chi for health benefits in patients with multiple sclerosis: A systematic review.
    PLoS One. 2017;12:e0170212.
    PubMed     Abstract available

  485. NA W, Yi K, Song YS, Park MH, et al
    Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
    PLoS One. 2017;12:e0174501.
    PubMed     Abstract available

  486. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Abstract available

  487. LUDVIGSSON J, Jones MP, Faresjo A
    Worm infestations and development of autoimmunity in children - The ABIS study.
    PLoS One. 2017;12:e0173988.
    PubMed     Abstract available

  488. CECCARELLI F, Sciandrone M, Perricone C, Galvan G, et al
    Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
    PLoS One. 2017;12:e0174200.
    PubMed     Abstract available

  489. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Abstract available

  490. FAIZY TD, Thaler C, Ceyrowski T, Broocks G, et al
    Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.
    PLoS One. 2017;12:e0172923.
    PubMed     Abstract available

  491. MIZUNO M, Noto D, Kaga N, Chiba A, et al
    The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models.
    PLoS One. 2017;12:e0173032.
    PubMed     Abstract available

  492. BLOSS S, Klemann C, Rother AK, Mehmecke S, et al
    Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.
    PLoS One. 2017;12:e0172532.
    PubMed     Abstract available

  493. REGNELL SE, Hessner MJ, Jia S, Akesson L, et al
    Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats.
    PLoS One. 2017;12:e0171372.
    PubMed     Abstract available

  494. MOON Y, McGinnis RS, Seagers K, Motl RW, et al
    Monitoring gait in multiple sclerosis with novel wearable motion sensors.
    PLoS One. 2017;12:e0171346.
    PubMed     Abstract available

  495. NICHOLAS D, Proctor EA, Raval FM, Ip BC, et al
    Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis.
    PLoS One. 2017;12:e0170975.
    PubMed     Abstract available

  496. LINK J, Ramanujam R, Auer M, Ryner M, et al
    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
    PLoS One. 2017;12:e0170395.
    PubMed     Abstract available

  497. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Abstract available

  498. DILLON MP, Fortington LV, Akram M, Erbas B, et al
    Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12.
    PLoS One. 2017;12:e0170705.
    PubMed     Abstract available

  499. ETCHEGARAY-MORALES I, Mendez-Martinez S, Jimenez-Hernandez C, Mendoza-Pinto C, et al
    Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.
    PLoS One. 2017;12:e0170209.
    PubMed     Abstract available

  500. UECKER FC, Olze H, Kunte H, Gerz C, et al
    Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.
    PLoS One. 2017;12:e0170492.
    PubMed     Abstract available

  501. HURTADO-GUERRERO I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, et al
    Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNss in Multiple Sclerosis Patients According to the Therapeutic Response to IFNss.
    PLoS One. 2017;12:e0170031.
    PubMed     Abstract available

  502. TIMILSHINA M, Kang Y, Dahal I, You Z, et al
    BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.
    PLoS One. 2017;12:e0168942.
    PubMed     Abstract available

  503. ELOI M, Horvath DV, Ortega JC, Prado MS, et al
    25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.
    PLoS One. 2017;12:e0170323.
    PubMed     Abstract available

  504. LIBERTINOVA J, Meluzinova E, Tomek A, Horakova D, et al
    Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNbeta.
    PLoS One. 2017;12:e0169957.
    PubMed     Abstract available

  505. AZZI J, Thueson L, Moore R, Abdoli R, et al
    PI3Kgamma Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    PLoS One. 2017;12:e0169695.
    PubMed     Abstract available

  506. FARIA BF, Mostardinha P, Vistulo de Abreu F
    Can the Immune System Perform a t-Test?
    PLoS One. 2017;12:e0169464.
    PubMed     Abstract available

  507. ESSIEN O, Otu A, Umoh V, Enang O, et al
    Intensive Patient Education Improves Glycaemic Control in Diabetes Compared to Conventional Education: A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital.
    PLoS One. 2017;12:e0168835.
    PubMed     Abstract available

  508. BROCHET B, Deloire MS, Perez P, Loock T, et al
    Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2017;12:e0168834.
    PubMed     Abstract available

  509. LAND J, Abdulahad WH, Arends S, Sanders JF, et al
    Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    PLoS One. 2017;12:e0182549.
    PubMed     Abstract available

  510. VAN ESDONK MJ, Tai B, Cotterill A, Charles B, et al
    Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.
    PLoS One. 2017;12:e0182181.
    PubMed     Abstract available

  511. WAUGH K, Snell-Bergeon J, Michels A, Dong F, et al
    Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
    PLoS One. 2017;12:e0174840.
    PubMed     Abstract available

  512. ZHAO Y, Healy BC, Rotstein D, Guttmann CR, et al
    Exploration of machine learning techniques in predicting multiple sclerosis disease course.
    PLoS One. 2017;12:e0174866.
    PubMed     Abstract available

  513. KIIRE CA, Horak K, Lee KE, Klein BE, et al
    The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study.
    PLoS One. 2017;12:e0174979.
    PubMed     Abstract available

  514. HEGEN H, Auer M, Bsteh G, Di Pauli F, et al
    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.
    PLoS One. 2017;12:e0174005.
    PubMed     Abstract available

  515. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Abstract available

  516. NICKERSON KM, Wang Y, Bastacky S, Shlomchik MJ, et al
    Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
    PLoS One. 2017;12:e0173471.
    PubMed     Abstract available

  517. LIMA PD, Chen Z, Tayab A, Murphy MS, et al
    Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    PLoS One. 2017;12:e0172988.
    PubMed     Abstract available

  518. WENDEBOURG MJ, Heesen C, Finlayson M, Meyer B, et al
    Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
    PLoS One. 2017;12:e0173025.
    PubMed     Abstract available

  519. EUESDEN J, Danese A, Lewis CM, Maughan B, et al
    A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study.
    PLoS One. 2017;12:e0173015.
    PubMed     Abstract available

  520. ONO N, Murakami K, Chan O, Hall H, et al
    Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes.
    PLoS One. 2017;12:e0173176.
    PubMed     Abstract available

  521. POURCINE F, Dahan K, Mihout F, Cachanado M, et al
    Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    PLoS One. 2017;12:e0173201.
    PubMed     Abstract available

  522. MORANDI E, Tanasescu R, Tarlinton RE, Constantinescu CS, et al
    The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172415.
    PubMed     Abstract available

  523. BEHBEHANI R, Abu Al-Hassan A, Al-Salahat A, Sriraman D, et al
    Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    PLoS One. 2017;12:e0172120.
    PubMed     Abstract available

  524. VAITAITIS GM, Yussman MG, Waid DM, Wagner DH Jr, et al
    Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    PLoS One. 2017;12:e0172037.
    PubMed     Abstract available

  525. HISA K, Yanagimachi MD, Naruto T, Miyamae T, et al
    PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    PLoS One. 2017;12:e0171961.
    PubMed     Abstract available

  526. MOCCIA M, Palladino R, Lanzillo R, Carotenuto A, et al
    Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.
    PLoS One. 2017;12:e0169489.
    PubMed     Abstract available

  527. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Abstract available

  528. MAGNUSSON K, Bech Holte K, Juel NG, Brox JI, et al
    Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study.
    PLoS One. 2017;12:e0177118.
    PubMed     Abstract available

  529. LAM HV, Nguyen DT, Nguyen CD
    Sibling method increases risk assessment estimates for type 1 diabetes.
    PLoS One. 2017;12:e0176341.
    PubMed     Abstract available

  530. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Abstract available

  531. SCOTT A, Chambers D, Goyder E, O'Cathain A, et al
    Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.
    PLoS One. 2017;12:e0177210.
    PubMed     Abstract available

  532. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Abstract available

  533. NIEGOWSKA M, Delitala A, Pes GM, Delitala G, et al
    Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.
    PLoS One. 2017;12:e0176584.
    PubMed     Abstract available

  534. MARINO KR, Lundberg RL, Jasrotia A, Maranda LS, et al
    A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    PLoS One. 2017;12:e0176860.
    PubMed     Abstract available

  535. IZQUIERDO G, Damas F, Paramo MD, Ruiz-Pena JL, et al
    The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
    PLoS One. 2017;12:e0176174.
    PubMed     Abstract available

  536. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Abstract available

  537. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Abstract available

  538. ZHAN Z, Yang Y, Zhan Y, Chen D, et al
    Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    PLoS One. 2017;12:e0176457.
    PubMed     Abstract available

  539. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Abstract available

  540. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Abstract available

  541. TALMAGE GD, Coppes OJM, Javed A, Bernard J, et al
    Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
    PLoS One. 2017;12:e0173299.
    PubMed     Abstract available

  542. HARRIS VK, Bell L, Langan RA, Tuddenham J, et al
    Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    PLoS One. 2017;12:e0175575.
    PubMed     Abstract available

  543. GIESS RM, Pfuhl C, Behrens JR, Rasche L, et al
    Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    PLoS One. 2017;12:e0175279.
    PubMed     Abstract available

  544. DOBRAKOWSKI P, Bogocz M, Cholewa K, Rajchel M, et al
    Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
    PLoS One. 2017;12:e0175156.
    PubMed     Abstract available

  545. HANAOKA H, Kiyokawa T, Iida H, Ishimori K, et al
    Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    PLoS One. 2017;12:e0175152.
    PubMed     Abstract available

  546. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Abstract available

  547. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Abstract available

  548. AYUSO T, Aznar P, Soriano L, Olaskoaga A, et al
    Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    PLoS One. 2017;12:e0174726.
    PubMed     Abstract available

  549. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Abstract available

  550. MULS N, Nasr Z, Dang HA, Sindic C, et al
    IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
    PLoS One. 2017;12:e0173780.
    PubMed     Abstract available

  551. HIROOKA K, Saito W, Namba K, Mizuuchi K, et al
    Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    PLoS One. 2017;12:e0172612.
    PubMed     Abstract available

  552. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Abstract available

  553. RAGHAV A, Ahmad J, Alam K
    Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    PLoS One. 2017;12:e0176970.
    PubMed     Abstract available

  554. TAKEUCHI Y, Saito A, Ojima Y, Kagaya S, et al
    The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study.
    PLoS One. 2017;12:e0177482.
    PubMed     Abstract available

  555. MOLINA-JIJON E, Rodriguez-Munoz R, Gonzalez-Ramirez R, Namorado-Tonix C, et al
    Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    PLoS One. 2017;12:e0177362.
    PubMed     Abstract available

  556. CHARVET LE, Yang J, Shaw MT, Sherman K, et al
    Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    PLoS One. 2017;12:e0177177.
    PubMed     Abstract available

  557. BOUGNERES P, Le Fur S, Valtat S, Kamatani Y, et al
    Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.
    PLoS One. 2017;12:e0170658.
    PubMed     Abstract available

  558. TSAI FJ, Chen SY, Liu YC, Liao HY, et al
    The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice.
    PLoS One. 2017;12:e0181423.
    PubMed     Abstract available

  559. YUN JS, Bae JM, Kim KJ, Jung YS, et al
    Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
    PLoS One. 2017;12:e0179088.
    PubMed     Abstract available

  560. PARDO E, Carcamo C, Uribe-San Martin R, Ciampi E, et al
    Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    PLoS One. 2017;12:e0177472.
    PubMed     Abstract available

  561. LUNDBERG M, Lindqvist A, Wierup N, Krogvold L, et al
    The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes.
    PLoS One. 2017;12:e0179911.
    PubMed     Abstract available

  562. TAUBERT R, Hardtke-Wolenski M, Noyan F, Lalanne C, et al
    Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.
    PLoS One. 2017;12:e0179074.
    PubMed     Abstract available

  563. PAUZUOLIS M, Eich T, Burman J
    Quantification of gammadelta T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.
    PLoS One. 2017;12:e0179095.
    PubMed     Abstract available

  564. CHAMI M, Halmer R, Schnoeder L, Anne Becker K, et al
    Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    PLoS One. 2017;12:e0178622.
    PubMed     Abstract available

  565. GUARDIA-OLMOS J, Gallardo-Moreno GB, Gudayol-Ferre E, Pero-Cebollero M, et al
    Effect of verbal task complexity in a working memory paradigm in patients with type 1 diabetes. A fMRI study.
    PLoS One. 2017;12:e0178172.
    PubMed     Abstract available

  566. MIYAWAKI Y, Katsuyama T, Sada KE, Hiramatsu S, et al
    A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
    PLoS One. 2017;12:e0178018.
    PubMed     Abstract available

  567. PARK JY, Yang HK, Hwang JM
    Diagnostic value of repeated ice tests in the evaluation of ptosis in myasthenia gravis.
    PLoS One. 2017;12:e0177078.
    PubMed     Abstract available

  568. LU G, Zhang X, Shen L, Qiao Q, et al
    CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy.
    PLoS One. 2017;12:e0178352.
    PubMed     Abstract available

  569. GUO R, Zhou Y, Lu L, Cao L, et al
    Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease.
    PLoS One. 2017;12:e0177774.
    PubMed     Abstract available

  570. SEOK JM, Choi M, Cho EB, Lee HL, et al
    Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life.
    PLoS One. 2017;12:e0177230.
    PubMed     Abstract available

  571. NISHIKAI-YAN SHEN T, Kanazawa S, Kado M, Okada K, et al
    Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice.
    PLoS One. 2017;12:e0178232.
    PubMed     Abstract available

  572. MOLLISON D, Sellar R, Bastin M, Mollison D, et al
    The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177727.
    PubMed     Abstract available

  573. ALSOP J, Medin J, Cornelissen C, Vormfelde SV, et al
    Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.
    PLoS One. 2017;12:e0173353.
    PubMed     Abstract available

  574. TONGYOO P, Avihingsanon Y, Prom-On S, Mutirangura A, et al
    EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes.
    PLoS One. 2017;12:e0177119.
    PubMed     Abstract available

  575. IP FCF, Ng YP, Or TCT, Sun P, et al
    Anemoside A3 ameliorates experimental autoimmune encephalomyelitis by modulating T helper 17 cell response.
    PLoS One. 2017;12:e0182069.
    PubMed     Abstract available

  576. BSTEH G, Ehling R, Walchhofer LM, Hegen H, et al
    Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study.
    PLoS One. 2017;12:e0181458.
    PubMed     Abstract available

  577. GARCIA TS, Rech TH, Leitao CB
    Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.
    PLoS One. 2017;12:e0180911.
    PubMed     Abstract available

  578. BERNITSAS E, Khan O, Razmjou S, Tselis A, et al
    Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.
    PLoS One. 2017;12:e0181431.
    PubMed     Abstract available

  579. TORTOSA C, Cabrera-Marante O, Serrano M, Martinez-Flores JA, et al
    Incidence of thromboembolic events in asymptomatic carriers of IgA anti ss2 glycoprotein-I antibodies.
    PLoS One. 2017;12:e0178889.
    PubMed     Abstract available

  580. LEISS H, Salzberger W, Jacobs B, Gessl I, et al
    MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.
    PLoS One. 2017;12:e0181015.
    PubMed     Abstract available

  581. DIESTELHORST J, Junge N, Schlue J, Falk CS, et al
    Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    PLoS One. 2017;12:e0181107.
    PubMed     Abstract available

  582. REIMER A, Schmitt A, Ehrmann D, Kulzer B, et al
    Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study.
    PLoS One. 2017;12:e0181218.
    PubMed     Abstract available

  583. HAUPT-JORGENSEN M, Nielsen E, Engkilde K, Lerche M, et al
    Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study.
    PLoS One. 2017;12:e0181143.
    PubMed     Abstract available

  584. WHEELOCK KM, Cai J, Looker HC, Merchant ML, et al
    Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    PLoS One. 2017;12:e0180964.
    PubMed     Abstract available

  585. SILVA SL, Albuquerque A, Amaral AJ, Li QZ, et al
    Autoimmunity and allergy control in adults submitted to complete thymectomy early in infancy.
    PLoS One. 2017;12:e0180385.
    PubMed     Abstract available

  586. RIGHART R, Schmidt P, Dahnke R, Biberacher V, et al
    Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients.
    PLoS One. 2017;12:e0179590.
    PubMed     Abstract available

  587. TAKAHASHI H, Nishimura R, Onda Y, Ando K, et al
    Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.
    PLoS One. 2017;12:e0177283.
    PubMed     Abstract available

  588. TOVOTE KA, Schroevers MJ, Snippe E, Emmelkamp PMG, et al
    What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes.
    PLoS One. 2017;12:e0179941.
    PubMed     Abstract available

  589. ROBERTS FR, Hupple C, Norowski E, Walsh NC, et al
    Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model.
    PLoS One. 2017;12:e0178641.
    PubMed     Abstract available

  590. SATO K, Nishijima T, Yokokawa T, Fujita S, et al
    Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes.
    PLoS One. 2017;12:e0178505.
    PubMed     Abstract available

  591. MCGINNIS RS, Mahadevan N, Moon Y, Seagers K, et al
    A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.
    PLoS One. 2017;12:e0178366.
    PubMed     Abstract available

  592. NYALWIDHE JO, Grzesik WJ, Burch TC, Semeraro ML, et al
    Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetes.
    PLoS One. 2017;12:e0183908.
    PubMed     Abstract available

  593. GRANADOS HM, Draghi A 2nd, Tsurutani N, Wright K, et al
    Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes.
    PLoS One. 2017;12:e0183887.
    PubMed     Abstract available

  594. THALER C, Schneider T, Sedlacik J, Kutzner D, et al
    T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis.
    PLoS One. 2017;12:e0183099.
    PubMed     Abstract available

  595. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment.
    PLoS One. 2017;12:e0182479.
    PubMed     Abstract available

  596. TAKAYASU L, Suda W, Watanabe E, Fukuda S, et al
    A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes.
    PLoS One. 2017;12:e0180863.
    PubMed     Abstract available

  597. VILLANI M, Nanayakkara N, Ranasinha S, Earnest A, et al
    Utilisation of prehospital emergency medical services for hyperglycaemia: A community-based observational study.
    PLoS One. 2017;12:e0182413.
    PubMed     Abstract available

  598. DE RIVA A, Wallberg M, Ronchi F, Coulson R, et al
    Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.
    PLoS One. 2017;12:e0181964.
    PubMed     Abstract available

  599. MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
    PLoS One. 2017;12:e0181564.
    PubMed     Abstract available

  600. LEE KY, Yoo BW, Ahn SS, Bae WH, et al
    Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
    PLoS One. 2017;12:e0181590.
    PubMed     Abstract available

  601. LANDI D, Albanese M, Buttari F, Monteleone F, et al
    Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study.
    PLoS One. 2017;12:e0165415.
    PubMed     Abstract available

  602. REVEIZ L, Haby MM, Martinez-Vega R, Pinzon-Flores CE, et al
    Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols.
    PLoS One. 2017;12:e0180220.
    PubMed     Abstract available

  603. NEGI S, Singh H, Mukhopadhyay A
    Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study.
    PLoS One. 2017;12:e0180518.
    PubMed     Abstract available

  604. CHANG YW, Chou YC, Yeh CC, Hu CJ, et al
    Outcomes after major surgery in patients with myasthenia gravis: A nationwide matched cohort study.
    PLoS One. 2017;12:e0180433.
    PubMed     Abstract available

  605. JONAS SF, Mbogning C, Hassler S, Broet P, et al
    A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.
    PLoS One. 2017;12:e0179896.
    PubMed     Abstract available

  606. CHARALAMPOPOULOS D, Hesketh KR, Amin R, Paes VM, et al
    Psycho-educational interventions for children and young people with Type 1 Diabetes in the UK: How effective are they? A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179685.
    PubMed     Abstract available

  607. TANG KT, Hsieh TY, Chao YH, Lin MX, et al
    Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
    PLoS One. 2017;12:e0178404.
    PubMed     Abstract available

  608. EBBO M, Grados A, Samson M, Groh M, et al
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    PLoS One. 2017;12:e0183844.
    PubMed     Abstract available

  609. REN S, Wang Y, Xian L, Toyama T, et al
    Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    PLoS One. 2017;12:e0184398.
    PubMed     Abstract available

  610. WURTH S, Kuenz B, Bsteh G, Ehling R, et al
    Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    PLoS One. 2017;12:e0182462.
    PubMed     Abstract available

  611. LIN TS, Hsu PY, Chang CH, Ko CL, et al
    Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
    PLoS One. 2017;12:e0182344.
    PubMed     Abstract available

  612. MESSINA S, Solaro C, Righini I, Bergamaschi R, et al
    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
    PLoS One. 2017;12:e0180651.
    PubMed     Abstract available

  613. KARAMPETSOU MP, Comte D, Kis-Toth K, Kyttaris VC, et al
    Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus.
    PLoS One. 2017;12:e0186073.
    PubMed     Abstract available

  614. MARITATI F, Alberici F, Oliva E, Urban ML, et al
    Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    PLoS One. 2017;12:e0185880.
    PubMed     Abstract available

  615. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Abstract available

  616. KISO K, Yoshifuji H, Oku T, Hikida M, et al
    Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.
    PLoS One. 2017;12:e0184738.
    PubMed     Abstract available

  617. ZHU H, Lemos H, Bhatt B, Islam BN, et al
    Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity.
    PLoS One. 2017;12:e0183484.
    PubMed     Abstract available

  618. DIAZ-RIZO V, Bonilla-Lara D, Gonzalez-Lopez L, Sanchez-Mosco D, et al
    Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis.
    PLoS One. 2017;12:e0184056.
    PubMed     Abstract available

  619. NEEDELL JC, Ir D, Robertson CE, Kroehl ME, et al
    Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.
    PLoS One. 2017;12:e0183786.
    PubMed     Abstract available

  620. MAULUCCI G, Cordelli E, Rizzi A, De Leva F, et al
    Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus.
    PLoS One. 2017;12:e0184109.
    PubMed     Abstract available

  621. MANUWALD U, Heinke P, Salzsieder E, Hegewald J, et al
    Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany.
    PLoS One. 2017;12:e0183665.
    PubMed     Abstract available

  622. PUTHENPARAMPIL M, Federle L, Poggiali D, Miante S, et al
    Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis.
    PLoS One. 2017;12:e0183957.
    PubMed     Abstract available

  623. BLAZER A, Wang B, Simpson D, Kirchhoff T, et al
    Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
    PLoS One. 2017;12:e0182483.
    PubMed     Abstract available

  624. CEUNINCK VAN CAPELLE A, Meide HV, Vosman FJH, Visser LH, et al
    A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT's) in multiple sclerosis (MS).
    PLoS One. 2017;12:e0182806.
    PubMed     Abstract available

  625. ABDELHAK A, Hottenrott T, Mayer C, Hintereder G, et al
    CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.
    PLoS One. 2017;12:e0182647.
    PubMed     Abstract available

  626. MODICA CM, Schweser F, Sudyn ML, Bertolino N, et al
    Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0182729.
    PubMed     Abstract available

  627. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Abstract available

  628. SONG F, Qian Y, Peng X, Li X, et al
    The frontline of immune response in peripheral blood.
    PLoS One. 2017;12:e0182294.
    PubMed     Abstract available

  629. WASHBURN N, Meccariello R, Hu S, Hains M, et al
    High-resolution physicochemical characterization of different intravenous immunoglobulin products.
    PLoS One. 2017;12:e0181251.
    PubMed     Abstract available

  630. SILVA-VILCHES C, Pletinckx K, Lohnert M, Pavlovic V, et al
    Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion.
    PLoS One. 2017;12:e0178114.
    PubMed     Abstract available

  631. KIDD T, Carey N, Mold F, Westwood S, et al
    A systematic review of the effectiveness of self-management interventions in people with multiple sclerosis at improving depression, anxiety and quality of life.
    PLoS One. 2017;12:e0185931.
    PubMed     Abstract available

  632. HU WS, Rajendran P, Tzang BS, Yeh YL, et al
    Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.
    PLoS One. 2017;12:e0185098.
    PubMed     Abstract available

  633. KIM HH, Jeong IH, Hyun JS, Kong BS, et al
    Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    PLoS One. 2017;12:e0181758.
    PubMed     Abstract available

  634. ITOH Y, Voskuhl RR
    Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    PLoS One. 2017;12:e0181349.
    PubMed     Abstract available

  635. FAVARETTO A, Lazzarotto A, Riccardi A, Pravato S, et al
    Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis.
    PLoS One. 2017;12:e0185626.
    PubMed     Abstract available

  636. MAKINO T, Nakamura R, Terakawa M, Muneoka S, et al
    Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
    PLoS One. 2017;12:e0185976.
    PubMed     Abstract available

  637. LUO W, Zhou B, Luo Q, Fang H, et al
    Polymorphism of keratin 1 associates with systemic lupus erythematosus and systemic sclerosis in a south Chinese population.
    PLoS One. 2017;12:e0186409.
    PubMed     Abstract available

  638. PERROTTI PP, Aterido A, Fernandez-Nebro A, Canete JD, et al
    Genetic variation associated with cardiovascular risk in autoimmune diseases.
    PLoS One. 2017;12:e0185889.
    PubMed     Abstract available

  639. MIETTINEN ME, Smart MC, Kinnunen L, Harjutsalo V, et al
    Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.
    PLoS One. 2017;12:e0184942.
    PubMed     Abstract available

  640. KURIAN SM, Ferreri K, Wang CH, Todorov I, et al
    Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice.
    PLoS One. 2017;12:e0185331.
    PubMed     Abstract available

  641. LIN JD, Yang SF, Wang YH, Fang WF, et al
    Associations of melatonin receptor gene polymorphisms with Graves' disease.
    PLoS One. 2017;12:e0185529.
    PubMed     Abstract available

  642. BERGGREN O, Hagberg N, Alexsson A, Weber G, et al
    Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype.
    PLoS One. 2017;12:e0183946.
    PubMed     Abstract available

  643. MASUDA H, Hirano S, Takahashi N, Hatsugano E, et al
    Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder.
    PLoS One. 2017;12:e0184012.
    PubMed     Abstract available

  644. RAIMONDO MG, Pericleous C, Radziszewska A, Borghi MO, et al
    Oxidation of beta2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
    PLoS One. 2017;12:e0186513.
    PubMed     Abstract available

  645. FERNANDEZ O, Duran E, Ayuso T, Hernandez L, et al
    Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).
    PLoS One. 2017;12:e0185766.
    PubMed     Abstract available

  646. ASANO T, Ito H, Kariya Y, Hoshi K, et al
    Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
    PLoS One. 2017;12:e0186414.
    PubMed     Abstract available

  647. POPPERUD TH, Viken MK, Kerty E, Lie BA, et al
    Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.
    PLoS One. 2017;12:e0186383.
    PubMed     Abstract available

  648. BESELER C, Vollmer T, Graner M, Yu X, et al
    The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    PLoS One. 2017;12:e0186842.
    PubMed     Abstract available

  649. GUSTAFSSON P, Crenshaw AG, Edmundsson D, Toolanen G, et al
    Muscle oxygenation in Type 1 diabetic and non-diabetic patients with and without chronic compartment syndrome.
    PLoS One. 2017;12:e0186790.
    PubMed     Abstract available

  650. WU YD, Lin CH, Chao WC, Liao TL, et al
    Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0187075.
    PubMed     Abstract available

  651. GOLEBIEWSKA J, Olechowski A, Wysocka-Mincewicz M, Odrobina D, et al
    Optical coherence tomography angiography vessel density in children with type 1 diabetes.
    PLoS One. 2017;12:e0186479.
    PubMed     Abstract available

  652. KENDRICK SK, Zheng Q, Garbett NC, Brock GN, et al
    Application and interpretation of functional data analysis techniques to differential scanning calorimetry data from lupus patients.
    PLoS One. 2017;12:e0186232.
    PubMed     Abstract available

  653. AL HARIRI M, Elmedawar M, Zhu R, Jaffa MA, et al
    Proteome profiling in the aorta and kidney of type 1 diabetic rats.
    PLoS One. 2017;12:e0187752.
    PubMed     Abstract available

  654. MARGIOTTA DPE, Basta F, Dolcini G, Batani V, et al
    The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus.
    PLoS One. 2017;12:e0187645.
    PubMed     Abstract available

  655. CONTRERAS I, Oviedo S, Vettoretti M, Visentin R, et al
    Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models.
    PLoS One. 2017;12:e0187754.
    PubMed     Abstract available

  656. HONORAT JA, Nakatsuji Y, Shimizu M, Kinoshita M, et al
    Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner.
    PLoS One. 2017;12:e0187215.
    PubMed     Abstract available

  657. RAKNES G, Smabrekke L
    Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study.
    PLoS One. 2017;12:e0187423.
    PubMed     Abstract available

  658. INAGAKI K, Yasuda Y, Ando M, Kaihan AB, et al
    Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission.
    PLoS One. 2017;12:e0187607.
    PubMed     Abstract available

  659. OKA S, Furukawa H, Yasunami M, Kawasaki A, et al
    HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
    PLoS One. 2017;12:e0187325.
    PubMed     Abstract available

  660. ESTEVE C, Samson M, Guilhem A, Nicolas B, et al
    Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    PLoS One. 2017;12:e0187296.
    PubMed     Abstract available

  661. HOUSHMAND-OEREGAARD A, Hjort L, Kelstrup L, Hansen NS, et al
    DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy.
    PLoS One. 2017;12:e0187038.
    PubMed     Abstract available

  662. LIN SJ, Kuo ML, Hsiao HS, Lee PT, et al
    Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.
    PLoS One. 2017;12:e0186223.
    PubMed     Abstract available

  663. CHOI JY, Jung JH, Shin S, Kim YH, et al
    Association between the pancreas transplantation and survival of patients with diabetes: A single center experience.
    PLoS One. 2017;12:e0186827.
    PubMed     Abstract available

  664. AL-RUBEAAN K, Almashouq MK, Youssef AM, Al-Qumaidi H, et al
    All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia.
    PLoS One. 2017;12:e0188097.
    PubMed     Abstract available

  665. MOISSET X, Perie M, Pereira B, Dumont E, et al
    Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study.
    PLoS One. 2017;12:e0188120.
    PubMed     Abstract available

  666. MIYAZAWA M, Takatori H, Shimakami T, Kawaguchi K, et al
    Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    PLoS One. 2017;12:e0188549.
    PubMed     Abstract available

  667. NAVARRO-QUIROZ E, Pacheco-Lugo L, Navarro-Quiroz R, Lorenzi H, et al
    Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
    PLoS One. 2017;12:e0187973.
    PubMed     Abstract available

  668. DUNHAM J, van de Vis R, Bauer J, Wubben J, et al
    Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey.
    PLoS One. 2017;12:e0188013.
    PubMed     Abstract available

  669. WEN J, Yablonskiy DA, Salter A, Cross AH, et al
    Limbic system damage in MS: MRI assessment and correlations with clinical testing.
    PLoS One. 2017;12:e0187915.
    PubMed     Abstract available

  670. LADFORS L, Shaat N, Wiberg N, Katasarou A, et al
    Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.
    PLoS One. 2017;12:e0187917.
    PubMed     Abstract available

  671. KORF H, Breser L, Van Hoeck J, Godoy J, et al
    MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.
    PLoS One. 2017;12:e0187455.
    PubMed     Abstract available

  672. DE GROOT PF, Belzer C, Aydin O, Levin E, et al
    Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study.
    PLoS One. 2017;12:e0188475.
    PubMed     Abstract available

  673. JONES IV AR, Coleman EL, Husni NR, Deeney JT, et al
    Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells.
    PLoS One. 2017;12:e0188474.
    PubMed     Abstract available

  674. TANG X, Zhao S, Chiu APY, Wang X, et al
    Analysing increasing trends of Guillain-Barre Syndrome (GBS) and dengue cases in Hong Kong using meteorological data.
    PLoS One. 2017;12:e0187830.
    PubMed     Abstract available

  675. HORVEI KD, Pedersen HL, Fismen S, Thiyagarajan D, et al
    Lupus nephritis progression in FcgammaRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.
    PLoS One. 2017;12:e0188863.
    PubMed     Abstract available

  676. PARKKOLA A, Laine AP, Karhunen M, Harkonen T, et al
    HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes.
    PLoS One. 2017;12:e0188402.
    PubMed     Abstract available

  677. LIU S, Liu X, Chen S, Xiao Y, et al
    Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0188644.
    PubMed     Abstract available

  678. YU MY, Kim YC, Koo HS, Chin HJ, et al
    Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    PLoS One. 2017;12:e0188375.
    PubMed     Abstract available

  679. DOUBLIER S, Zennaro C, Musante L, Spatola T, et al
    Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    PLoS One. 2017;12:e0188045.
    PubMed     Abstract available

  680. GARBETT NC, Brock GN, Chaires JB, Mekmaysy CS, et al
    Characterization and classification of lupus patients based on plasma thermograms.
    PLoS One. 2017;12:e0186398.
    PubMed     Abstract available

  681. WYBRECHT D, Reuter F, Pariollaud F, Zaaraoui W, et al
    New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
    PLoS One. 2017;12:e0184650.
    PubMed     Abstract available

  682. IRACE C, Messiniti V, Tassone B, Cortese C, et al
    Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes.
    PLoS One. 2017;12:e0187525.
    PubMed     Abstract available

  683. GROBELNY A, Behrens JR, Mertens S, Otte K, et al
    Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    PLoS One. 2017;12:e0189281.
    PubMed     Abstract available

  684. PERRI V, Gianchecchi E, Cifaldi L, Pellegrino M, et al
    Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers.
    PLoS One. 2017;12:e0189615.
    PubMed     Abstract available

  685. GREENFIELD J, Hudson M, Vinet E, Fortin PR, et al
    A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
    PLoS One. 2017;12:e0189840.
    PubMed     Abstract available

  686. CHEN Y, Zhen W, Guo T, Zhao Y, et al
    Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    PLoS One. 2017;12:e0189380.
    PubMed     Abstract available

  687. SASIDHAR MV, Chevooru SK, Eickelberg O, Hartung HP, et al
    Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    PLoS One. 2017;12:e0189701.
    PubMed     Abstract available

    January 2016
  688. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Abstract available

  689. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Abstract available

  690. MAGGI L, Margheri F, Luciani C, Capone M, et al
    Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.
    PLoS One. 2016;11:e0154422.
    PubMed     Abstract available

  691. RAMONDT S, Tiemensma J, Cameron LD, Broadbent E, et al
    Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study.
    PLoS One. 2016;11:e0154348.
    PubMed     Abstract available

  692. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Abstract available

  693. HAASNOOT AJ, Vernie LA, Rothova A, V D Doe P, et al
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016;11:e0164312.
    PubMed     Abstract available

  694. KAUSHIK DK, Yong HY, Hahn JN, Silva C, et al
    Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    PLoS One. 2016;11:e0163802.
    PubMed     Abstract available

  695. KALRON A, Givon U, Frid L, Dolev M, et al
    Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
    PLoS One. 2016;11:e0164467.
    PubMed     Abstract available

  696. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Abstract available

  697. RIEMANN-LORENZ K, Eilers M, von Geldern G, Schulz KH, et al
    Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
    PLoS One. 2016;11:e0165246.
    PubMed     Abstract available

  698. MANICARDI V, Russo G, Napoli A, Torlone E, et al
    Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016;11:e0162960.
    PubMed     Abstract available

  699. JERNAS L, Wencel J, Wiak A, Bieniek M, et al
    Risk Factors for Poor Adherence to Betaferon(R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.
    PLoS One. 2016;11:e0157950.
    PubMed     Abstract available

  700. OKANO J, Kojima H, Katagi M, Nakagawa T, et al
    Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.
    PLoS One. 2016;11:e0166215.
    PubMed     Abstract available

  701. DOBSON R, Ramagopalan S, Topping J, Smith P, et al
    A Risk Score for Predicting Multiple Sclerosis.
    PLoS One. 2016;11:e0164992.
    PubMed     Abstract available

  702. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Abstract available

  703. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Abstract available

  704. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Abstract available

  705. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Abstract available

  706. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Abstract available

  707. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Abstract available

  708. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Abstract available

  709. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Abstract available

  710. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Abstract available

  711. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Abstract available

  712. WANG X, Liu W, O'Donnell M, Lutgendorf S, et al
    Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    PLoS One. 2016;11:e0168772.
    PubMed     Abstract available

  713. PIVOT D, Debouverie M, Grzebyk M, Brassat D, et al
    Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    PLoS One. 2016;11:e0167556.
    PubMed     Abstract available

  714. MURIS AH, Smolders J, Rolf L, Klinkenberg LJ, et al
    Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    PLoS One. 2016;11:e0156122.
    PubMed     Abstract available

  715. STAMILE C, Kocevar G, Cotton F, Durand-Dubief F, et al
    A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
    PLoS One. 2016;11:e0156405.
    PubMed     Abstract available

  716. DORONIN VB, Parkhomenko TA, Castellazzi M, Cesnik E, et al
    Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0154688.
    PubMed     Abstract available

  717. YASUI J, Kawasaki E, Tanaka S, Awata T, et al
    Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    PLoS One. 2016;11:e0155643.
    PubMed     Abstract available

  718. CHEN HH, Lin IC, Chen HJ, Yeh SY, et al
    Association of Herpes Zoster and Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0155175.
    PubMed     Abstract available

  719. LAIBLE M, Jarius S, Mackensen F, Schmidt-Bacher A, et al
    Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0155322.
    PubMed     Abstract available

  720. BEGGS CB, Magnano C, Belov P, Krawiecki J, et al
    Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0153960.
    PubMed     Abstract available

  721. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Abstract available

  722. LAMPRIANOU S, Gysemans C, Bou Saab J, Pontes H, et al
    Glibenclamide Prevents Diabetes in NOD Mice.
    PLoS One. 2016;11:e0168839.
    PubMed     Abstract available

  723. SALEHI Z, Doosti R, Beheshti M, Janzamin E, et al
    Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    PLoS One. 2016;11:e0159565.
    PubMed     Abstract available

  724. BSTEH G, Ehling R, Lutterotti A, Hegen H, et al
    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
    PLoS One. 2016;11:e0158978.
    PubMed     Abstract available

  725. VIROSTKO J, Hilmes M, Eitel K, Moore DJ, et al
    Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    PLoS One. 2016;11:e0158825.
    PubMed     Abstract available

  726. LUIPPOLD G, Bedenik J, Voigt A, Grempler R, et al
    Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    PLoS One. 2016;11:e0156346.
    PubMed     Abstract available

  727. KARAMYAN A, Dunser MW, Wiebe DJ, Pilz G, et al
    Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
    PLoS One. 2016;11:e0155795.
    PubMed     Abstract available

  728. JELINEK GA, De Livera AM, Marck CH, Brown CR, et al
    Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
    PLoS One. 2016;11:e0161701.
    PubMed     Abstract available

  729. BINZ N, Rakoczy EP, Ali Rahman IS, Vagaja NN, et al
    Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
    PLoS One. 2016;11:e0160442.
    PubMed     Abstract available

  730. ABURAWI EH, AlKaabi J, Zoubeidi T, Shehab A, et al
    Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    PLoS One. 2016;11:e0159808.
    PubMed     Abstract available

  731. DARABIAN S, Backlund JY, Cleary PA, Sheidaee N, et al
    Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study.
    PLoS One. 2016;11:e0159958.
    PubMed     Abstract available

  732. DAVIES JL, Thompson S, Kaur-Sandhu H, Sawcer S, et al
    Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
    PLoS One. 2016;11:e0158327.
    PubMed     Abstract available

  733. DENNISON L, McCloy Smith E, Bradbury K, Galea I, et al
    How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
    PLoS One. 2016;11:e0158982.
    PubMed     Abstract available

  734. DAHL LC, Nasa Z, Chung J, Niego B, et al
    The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
    PLoS One. 2016;11:e0158653.
    PubMed     Abstract available

  735. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Abstract available

  736. VALLERIE SN, Kramer F, Barnhart S, Kanter JE, et al
    Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.
    PLoS One. 2016;11:e0158316.
    PubMed     Abstract available

  737. SATUE M, Rodrigo MJ, Otin S, Bambo MP, et al
    Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0157293.
    PubMed     Abstract available

  738. QIN W, Liang YZ, Qin BY, Zhang JL, et al
    The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
    PLoS One. 2016;11:e0156959.
    PubMed     Abstract available

  739. D'AMICO E, Leone C, Graziano G, Amato MP, et al
    The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
    PLoS One. 2016;11:e0157721.
    PubMed     Abstract available

  740. BOUDARHAM J, Hameau S, Zory R, Hardy A, et al
    Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0158267.
    PubMed     Abstract available

  741. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Abstract available

  742. RIQUELME MEDINA I, Lubovac-Pilav Z
    Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.
    PLoS One. 2016;11:e0156006.
    PubMed     Abstract available

  743. BUERTH C, Mausberg AK, Heininger MK, Hartung HP, et al
    Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    PLoS One. 2016;11:e0155082.
    PubMed     Abstract available

  744. MASSA MG, Gisevius B, Hirschberg S, Hinz L, et al
    Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0155274.
    PubMed     Abstract available

  745. MCEWAN P, Bennett H, Fellows J, Priaulx J, et al
    The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162441.
    PubMed     Abstract available

  746. SOLARO C, Trabucco E, Signori A, Martinelli V, et al
    Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
    PLoS One. 2016;11:e0160261.
    PubMed     Abstract available

  747. SAVASTIO S, Cadario F, Genoni G, Bellomo G, et al
    Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162554.
    PubMed     Abstract available

  748. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Abstract available

  749. BOHN B, Karges B, Vogel C, Otto KP, et al
    20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
    PLoS One. 2016;11:e0160971.
    PubMed     Abstract available

  750. FERNANDEZ O, Arroyo R, Martinez-Yelamos S, Marco M, et al
    Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart(R) Device in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0160313.
    PubMed     Abstract available

  751. GRACIEN RM, Jurcoane A, Wagner M, Reitz SC, et al
    The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0161036.
    PubMed     Abstract available

  752. HASEDA F, Imagawa A, Nishikawa H, Mitsui S, et al
    Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes.
    PLoS One. 2016;11:e0160576.
    PubMed     Abstract available

  753. IANNETTA M, Zingaropoli MA, Bellizzi A, Morreale M, et al
    Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    PLoS One. 2016;11:e0160277.
    PubMed     Abstract available

  754. GILLI F, Chen X, Pachner AR, Gimi B, et al
    High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0160071.
    PubMed     Abstract available

  755. MARTIN JE, Raffel J, Nicholas R
    Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
    PLoS One. 2016;11:e0159210.
    PubMed     Abstract available

  756. DASKALAKI E, Diem P, Mougiakakou SG
    Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.
    PLoS One. 2016;11:e0158722.
    PubMed     Abstract available

  757. ERNSTSSON O, Gyllensten H, Alexanderson K, Tinghog P, et al
    Cost of Illness of Multiple Sclerosis - A Systematic Review.
    PLoS One. 2016;11:e0159129.
    PubMed     Abstract available

  758. AKAMATSU M, Makino N, Ikeda Y, Matsuda A, et al
    Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    PLoS One. 2016;11:e0158669.
    PubMed     Abstract available

  759. OBERT D, Helms G, Sattler MB, Jung K, et al
    Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    PLoS One. 2016;11:e0162583.
    PubMed     Abstract available

  760. CLAUSEN TD, Bergholt T, Bouaziz O, Arpi M, et al
    Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.
    PLoS One. 2016;11:e0161654.
    PubMed     Abstract available

  761. FATIMA N, Faisal SM, Zubair S, Ajmal M, et al
    Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects.
    PLoS One. 2016;11:e0161548.
    PubMed     Abstract available

  762. MURAKAMI T, Uji A, Suzuma K, Dodo Y, et al
    In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography.
    PLoS One. 2016;11:e0160317.
    PubMed     Abstract available

  763. PAOLICELLI D, Iannazzo S, Santoni L, Iaffaldano A, et al
    The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
    PLoS One. 2016;11:e0159214.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.